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Tissue	 engineered	 skin	 has	 advanced	 significantly	 in	 creating	 a	 substitute	 to	
mimic	human	skin.	Advances	in	biomaterial	sciences	and	a	better	understanding	
of	wound	healing	have	been	the	catalyst	for	development	of	tissue-engineered	
skin	 substitutes.	We	 aimed	 to	 develop	 and	 evaluate	 a	 biodegradable	 dermal	
alternative	 composed	 of	 FDA	 approved	 polymers	 consisting	 of	 polyhydroxy-




The	 scaffolds	 consisted	 of	 an	 upper	 and	 under	 layer	 of	 PGLA	 75:25	which	 is	
known	to	facilitate	the	migration	of	epithelial	cells	and	a	middle	layer	of	PHBV	
to	act	as	a	basement	membrane	separating	the	epidermis	from	the	underlying	
















The	 ability	 for	 optimization	 of	 migration	 of	 cells	 from	 the	 skin	 explants	 was	
assessed	using	fibrin,	a	biological	tissue	glue	in	current	clinical	use	in	its	ability	










in	 the	presence	of	 isolated	 fibroblasts	pre-cultured	on	scaffolds	as	an	 in	vitro	
wound	 bed	 model.	 This	 revealed	 significantly	 increased	 metabolic	 and	
proliferative	 activity	 of	 constructs	 in	 production	 of	 collagen.	 Although	 in	 our	
model	for	clinical	translation	we	do	not	intend	to	use	isolated	fibroblasts	to	pre	
culture	scaffolds,	it	was	felt	that	this	was	the	closest	to	a	wound	bed	model	as	
the	 scaffolds	 would	 be	 placed	 onto	 a	 prepared	 wound	 bed.	
Immunohistochemistry	 was	 used	 to	 demonstrate	 that	 keratinocytes	 were	
migrating	 from	 the	 cut	 edges	 of	 the	 skin	 explants	 and	 confocal	 imaging	
demonstrated	that	the	cells	penetrated	the	layers	of	the	trilayer	scaffold.		
		





























The	skin	 is	 the	 largest	organ	 in	 the	body,	covering	around	2m2	 in	an	average	





healing	 by	 creating	 a	 skin	 substitute	 we	 must	 firstly	 understand	 the	





or	 the	 waterproofing	 layer;	 the	 dermis	 or	 the	 supportive	 layer	 and	 the	
hypodermis	or	the	padding	layer	(Figure	1.1).	Although	these	layers	have	been	














anuclear	 keratin	 cells	 that	make	up	 the	 stratum	corneum.	 Stratification	 is	 an	
essential	 feature	of	 the	 topography	of	 the	epidermis,	as	 cells	exist	 in	various	
stages	 of	 proliferation	 and	 differentiation	 in	 the	 differing	 layers.	 It	 is	 this	









thin	 layer	 of	 specialized	 extracellular	 matrix	 onto	 which	 the	 epidermis	 is	
attached.		It	serves	to	tightly	link	the	epidermis	to	the	dermis;	provides	a	barrier	
against	epidermal	migration;	determines	the	polarity	of	the	epidermis	and	acts	
as	 the	 middleman	 communicator	 between	 the	 epidermis	 and	 dermis	 to	
maintain	haemostasis,	which	is	one	of	the	main	functions	of	the	skin(4).	
Inoue	demonstrated	 that	 the	basement	membrane	 could	be	morphologically	
distinguished	into	four	layers:	the	plasma	membrane	of	the	basal	keratinocytes;	
lamina	lucida;	lamina	densa	and	sublamina	densa.	These	all	act	collectively	to	




of	 the	 basement	membrane.	 These	 integrins	 are	 known	 as	 laminin	 332	 and	









region	 are	 likely	 to	 experience.	 The	 basement	 membrane	 is	 topographically	
organized	 into	 peaks	 and	 troughs	 in	 the	 post-natal	 skin.	 These	 develop	mid-


















have	demonstrated,	using	biopsies	 followed	by	histological	 analysis,	 that	 this	























The	 papillary	 layer	 is	 undulating	 and	 intertwines	with	 the	 rete	 ridges	 of	 the	
epithelium	at	the	dermal-epidermal	junction.	Molecularly	it	consists	of	loosely	
arranged	type	III	collagen	fibres.		
The	 reticular	 dermis	 is	 composed	 of	 a	 dense	 irregular	 meshwork	 of	 tightly	
packed	 type	 I	 collagen	 fibres	 elastin	 and	 glycosaminoglycans	 (extracellular	
matrix).	Fibroblasts	in	the	dermis	are	primarily	responsible	for	the	synthesis	of	
the	 extracellular	matrix.	 The	 reticular	 dermis	 provides	 skin	 with	 elasticity	 or	
resilience	 to	 deformity.	 Therefore,	 any	 skin	 substitute	 must	 have	 a	 robust	
Undulating	pattern	of	the	Epidermal	-	Dermal	Interface
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dermal	 component,	which	 can	 support	 and	 facilitate	 collagen	deposition	and	












There	are	 two	horizontal	plexuses	or	vascular	 trees	 that	 supply	 the	 skin.	The	












In	order	 to	produce	a	scaffold	 that	supports	 the	growth	of	keratinocytes	and	
fibroblasts	 it	 is	 essential	 to	 understand	 their	 behaviour,	 organization	 and	
requirements.		Keratinocyte	migration	occurs	in	wound	healing	after	about	18-
24	hours.	 	Migrating	keratinocytes	are	morphologically	altered	in	order	to	aid	
this.	 Some	 of	 the	 changes	 include	 disassembly	 of	 the	 links	 	 between	 the	
basement	 membrane	 and	 the	 keratinocytes	 and	 retraction	 of	 intracellular	
filaments	 to	allow	propagation	and	 formation	of	peripheral	cytoplasmic	actin	
filaments	 (lamellopodia).	 Epithelization	 is	 controlled	 by	 communication	
between	 three	main	 sets	 of	molecules:	 growth	 factors,	 integrins	 and	matrix	
metalloproteinases	(MMPs)(15).	These	systems	all	integrate	to	form	a	migrating	
sheet	 of	 keratinocytes	 at	 the	 edge	 of	 the	 wound.	 The	 leading	 edge	 of	 this	
advancing	sheet	shows	no	mitotic	activity.	Instead	the	suprabasal	keratinocytes	
are	the	first	to	migrate	onto	the	wound;	this	reduces	the	number	of	cells	and	act	








Fibroblasts	 are	 the	 principal	 cellular	 components	 of	 connective	 tissues	 and	
populate	the	dermis	of	the	skin.	They	are	elongated,	spindle	shaped	cells	that	
have	 a	 high	 proliferative	 and	migration	 potential.	 They	 function	 not	 only	 to	
synthesize	and	secrete	extracellular	matrix	molecules	but	also	growth	factors,	
cytokines	 and	 chemokines	 that	 contribute	 to	 immune	 regulation	 and	wound	
healing	by	influencing	the	migration	and	proliferation	of	keratinocytes(17).		
Historical	data	has	demonstrated	that	fibroblasts	cultured	in	a	blood	clot	varied	
in	 shape	 from	stellate	 to	bipolar	depending	on	 the	orientation	of	 the	 fibrous	
network	 of	 the	 clot.	 This	 led	 to	 the	 conclusion	 that	 there	 was	 a	 dynamic	
interaction	between	cells	and	their	physical	environment(18).	When	fibroblasts	
are	cultured	within	an	extracellular	matrix	eg	fibrin	as	 is	planned	in	this	work	
they	 experience	 a	 richer,	 more	 complex	 physical	 environment	 and	 different	
geometry	 than	 cells	 on	 2D	 surfaces.	 Cells	 do	 not	 only	 migrate	 but	 work	 to	



























undertake	 this	due	 to	 the	proliferating	 cells	 that	 reside	 there.	There	are	 two	
main	types	of	proliferating	cells:	the	stem	cells	(SC)	and	the	transit	amplifying	














of	 the	 skin)(23).	 The	 stem	 cells	 that	 reside	 in	 these	 two	 areas	 have	 distinct	
functions	and	reside	in	different	microenvironments	or	niches	that	determine	
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One	 function	 of	 the	 rete	 ridges	 is	 to	 anchor	 the	 epidermis	 to	 the	 dermis,	
however	it	also	serves	to	create	a	microenvironment	for	the	IFE	stem	cells	at	the	
base	of	the	ridges.	This	is	a	more	protected	site	than	other	areas	of	the	IFE(12).	
The	 stem	 cells	 that	 reside	 in	 the	 rete	 ridges	 have	 been	 investigated	 using	
cultured	human	interfollicular	keratinocytes	which	have	determined	that	cells	
expressing	 the	 highest	 level	 of	 ß	 integrins	 have	 the	 highest	 proliferative	
potential	in	vitro(24).	These	so	called	ß1	bright	cells	are	found	especially	in	the	


















The	 work	 in	 this	 thesis	 investigates	 the	 use	 of	 skin	 explants	 as	 a	 source	 of	
fibroblasts	and	keratinocytes	as	opposed	to	using	isolated	laboratory	cultured	
















cells	 when	 not	 handled	 properly.	 	 There	 are	 no	 recommendations	 in	 the	
literature	on	the	size	that	the	pieces	need	to	be,	some	groups	have	used	a	4mm	





Historically	 a	 large	 portion	 of	 reconstructive	 surgery	 consists	 of	 autologous	
tissue	rearrangement	to	fill	defects	most	commonly	involving	soft	tissues	and	
skin,	 singularly	or	 in	 combination.	The	advancement	 in	 the	knowledge	of	 the	
vascular	 anatomy	 of	 the	 skin	 and	 the	 evolution	 of	 perforator	 flaps	 have	
decreased	 the	 morbidity	 that	 was	 associated	 with	 the	 original	 concept	 of	
robbing	 Peter	 to	 pay	 Paul.	 Here,	 skin	 and	 subcutaneous	 tissue	 or	 muscle	 if	
required	can	be	isolated	on	its	vascular	supply,	thereby	ensuring	its	viability.	This	
refinement	has	 led	 to	only	 taking	what	only	 is	 required,	which	 results	 in	 less	
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donor	 morbidity.	 For	 example,	 the	 workhorse	 abdominal	 flap	 has	 seen	 an	
evolution	 from	 using	 all	 of	 the	muscle	 of	 the	 abdominal	 wall	 which	 lead	 to	
hernias	to	now	only	using	the	skin	and	fat	which	has	a	quicker	recovery	and	less	
abdominal	wall	 insult.	Additionally,	 industry	has	weighed	 in	on	 this	evolution	
and	 produced	 better	 equipment	 for	 the	 microsurgical	 techniques	 that	 are	




due	 to	 burns,	 trauma	 or	 infection	 (necrotising	 fasciitis).	 Apart	 from	 a	 size	
limitation,	autologous	tissue	transfer	requires	optimal	conditions	for	success	for	
example	 the	 success	 of	 a	 skin	 graft	 is	 dependent	 on	 a	 non-infected,	 well	
vascularised	wound	bed	and	is	not	ideal	for	coverage	of	bare	tendon	or	bone	














generations	 of	 surgeons	 (Figure	 1.3).	 Although	 it	 has	 evolved	 overtime	 its	
message	remains	the	same:	a	logical	progression	of	the	surgical	approaches	that	
can	be	utilized	in	wound	healing.	The	earliest	descriptions	start	with	healing	via	
secondary	 intention	 (leaving	 a	 wound	 to	 granulate	 and	 ultimately	 heal	 with	
simple	dressings),	followed	by	direct	closure	with	sutures,	skin	grafts	and	flaps.	
A	flap	is	the	transfer	of	tissue	on	the	basis	of	its	vascular	anatomy	from	one	part	
of	 the	 body	 to	 another.	 It	 can	 consist	 of	 almost	 any	 tissue	 type,	 the	 most	
common	ones	being	skin,	skin	and	fascia,	skin	and	muscle	or	skin,	muscle	and	
bone.	 They	 have	 evolved	 significantly	 over	 the	 years	 in	 parallel	 with	 the	
increasing	knowledge	of	the	intricate	vasculature	to	the	skin.	Vascularization	is	
a	key	principle	 in	plastic	 surgery	as	 tissue	 reconstruction,	be	 it	autologous	or	
from	other	sources,	survives	by	the	establishment	of	a	good	blood	supply	in	a	








simplest	 option	 before	 moving	 to	 the	 next	 stage.	 The	 reconstructive	 ladder	
however	 despite	 its	 many	 modifications	 has	 not	 reflected	 the	 advances	 in	
wound	 healing,	 specifically	 the	 development	 and	 widespread	 use	 of	 dermal	
matrices.	 Dermal	matrices	 are	 dermal	 substitutes	 that	 are	 FDA	 approved	 for	
wound	cover.	Furthermore,	the	potential	contribution	that	tissue	engineering	
of	 skin	and	other	 tissues	 can	make	 to	 reconstruction	cannot	be	 ignored.	The	




(consisting	 of	 components	 of	 human	 or	 animal	 origin)	 or	 synthetic.	 This	 will	
facilitate	incorporation	of	these	products	as	routine	in	the	clinical	environment	






























skin	 grafts.	 Historically	 burn	 wounds	 were	 medically	 managed	 with	 topical	
therapies	applied	to	the	burn	eschar(32).	In	partial	thickness	burns	this	worked	
as,	regeneration	occurs	from	the	dermal	appendages	that	are	left	behand.	In	full	
thickness	 burns,	 once	 the	 eschar	 separates	 from	 the	 underlying	 wound	 bed	
there	 is	was	a	bed	of	 vascularized	granulation	 tissue	 suitable	 for	 subsequent	
grafting.	This	posed	morbidities	such	as	prolonged	wound	healing	 time,	pain,	
hypertrophic	scarring	and	contractures.	The	only	advantage	here	was	that	there	




grafting	 of	 smaller	 burns	 was	 described	 first	 in	 1891	 by	 Lusgarten(33).	 This	
principle	 was	 increasingly	 adopted	 by	 other	 groups	 with	 variable	
outcomes(34),(35).	It	was	only	in	1981	when	Janzekovic	reported	good	surgical	







on	 clinical	 assessment	 and	 mechanism	 of	 injury),	 initial	 conservative	





are	 often	 reconstructed	 with	 autologous	 split	 thickness	 grafts	 or	 dermal	
regenerative	templates	depending	on	the	site	of	the	wound.	Larger	burns	(>20%	
to	 50%	 TBSA)	 undergo	 as	much	 excision	 as	 possible	 and	 reconstruction	with	





The	 principle	 here	 is	 that	 by	 removing	 large	 quantities	 of	 eschar,	 there	 is	 a	





the	 patient	 during	 the	 procedure.	 Furthermore,	 with	 larger	 burns	 that	 are	





undertaken	 influences	 the	 reconstructive	 procedure	 and	 ultimately	 the	





outcomes	 such	 as	 delayed	 wound	 healing,	 pain	 and	 contracture	 increase	
exponentially.	 Commonly	 used	 ratios	 are	 1:2,	 1:4	 and	 1:6	 for	 major	 burns.	
Another	 option	 in	 this	 setting	 is	 the	 use	 of	 cadaver	 skin.	 This	 provides	 an	
immediate	barrier	that	prevents	evaporative	and	thermal	losses	and	allows	the	
patient	 to	stabilize,	 regenerate	used	donor	sites.	A	 return	 to	 theatre	about	3	
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weeks	 later	 is	 undertaken	 to	 remove	 the	 cadaver	 skin	 and	 graft	 onto	 the	
underlying	wound	bed.		
In	 the	 long	 term	 setting	 surgical	 intervention	 is	 centred	on	 scar	 revision	 and	
contracture	release.	Early	excision	is	proposed	as	a	technique	to	circumvent	this	
and	the	Burns	multidisciplinary	team	is	established	to	optimize	patient	care.	This	
can	 have	 a	 profound	 effect	 on	 scar	 outcome;	 however,	 there	 will	 be	 some	









deficit).	 Additionally,	 skin	 can	 be	 imported	 by	 using	 dermal	 regenerative	
templates.	The	general	consensus	is	that,	if	possible	full	thickness	grafts	or	flaps	
are	 the	 best	 options	 if	 available.	 This	 is	 because	 split	 skin	 grafts	 and	 dermal	
substitutes	have	a	significant	amount	of	secondary	contracture	compared	to	full	
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For	 example,	 the	 abdomen	 can	 provide	 large	 quantities	 of	 skin	 (depends	 on	







or	 a	 mastopexy	 (breast	 lift)	 (females	 only	 and	 males	 with	 gynecomastia	 or	
enlarged	breasts).	These	procedures	often	result	in	large	quantities	of	skin	and	
subcutaneous	fat	that	are	not	needed	by	the	patient.	Therefore,	full	thickness	




of	 reconstruction	 as	 it	 provides	 good	 colour	 and	 texture	 match	 and	 little	
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aftercare.	However,	these	are	limited	depending	on	the	site	and	size	of	the	skin	
defect	 resulting	 from	 the	 contracture	 release.	 Furthermore,	 even	 if	 suitable	





















rapid	 re-epithelization	 of	 wounds(39).	 This	 technique	 was	 associated	 with	
significant	 contracture	and	 therefore	 led	 to	 the	use	of	 strips	of	 tissue	placed	











edges	of	 the	split	 thickness	skin	explants.	Following	 this,	 surgeons	wanted	 to	
standardize	the	method	of	harvesting	grafts	so	as	to	get	a	fixed	proportion	of	
dermis	 needed	 for	 a	 particular	 application.	 This	 lead	 to	 the	 evolution	 of	 the	
various	instruments	used	to	harvest	a	graft.	In	the	late	19th	and	20th	centuries	
the	Humby	knife	was	used	however	dermal	thickness	was	still	not	reproducible	










Furthermore,	 expansion	 revolutionized	 the	 treatment	of	major	burns,	 as	 less	
donor	 sites	were	 needed	 to	 treat	 a	 given	 surface	 area	 of	 burn.	 Additionally,	
expanded	 grafts	 contour	 curves	 easier	 and	 the	 spaces	 in	 between	 the	 grafts	
allow	 for	 the	 extrusion	 of	 blood	 and	 tissue	 fluid	 that	 can	 collect	 under	 an	
unexpanded	 graft	 lifting	 it	 from	 the	 wound	 bed	 and	 resulting	 in	 a	 failed	
application.		
Category		 Standardized	thickness	inch;	mm		











In	 1958,	 Meek	 an	 American	 Surgeon	 proposed	 the	 development	 of	 a	
dermatome	 that	 allowed	 a	 1	 inch	 square	 of	 skin	 to	 be	 cut	 into	 256	 square	
pieces(45).	Meek	theorized	that	wound	re-epithelization	occurred	from	the	cut	
edges	 of	 the	 small	 squares	 of	 split	 thickness	 skin	 grafts	 therefore	 increasing	











skin	 graft	 square	 needed	 to	 be	 placed	 dermis	 side	 down	 (Figure	 1.4a).	 This	
technique	is	not	practical	for	large	burns	where	time	is	a	limiting	factor	in	the	
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initial	 excision	and	 reconstruction.	Over	 the	 years	many	modifications	 to	 the	
Meek	 technique	 have	 been	 explored	 (Figure	 1.4b)	 and	 good	 outcomes	 have	
been	reported	in	the	literature	with	regards	to	time	to	wound	re-epithelization	
leading	to	a	resurgence	 in	 its	usage	(Figure	1.5)(47),(48),(49).	This	principle	of	
keratinocyte	 migration	 in	 Meek	 Grafting	 can	 be	 used	 to	 populate	 the	 skin	
substitute	 with	 a	 patient’s	 own	 cells	 via	 small	 split	 thickness	 skin	 explants	

















from	 Elsevier.	MEEK	 CP.	 Successful	microdermagrafting	 using	 the	Meek-Wall	









































but	also	 the	physiology	of	 the	organ.	 In	 this	 respect	 skin	 substitutes	need	 to	











off	 the	 shelf	 that	 is	 easy	 to	 use	 are	 also	 desirable	 properties.	 Current	
biomaterials	 are	 not	 infection	 resistant	 and	 are	 actually	more	 susceptible	 to	
infection	than	autologous	skin.	A	study	by	Bargues	et	al(51),	demonstrated	that	
the	popularly	used	 Integra,	was	associated	with	a	42%	 infection	 rate	 in	 their	
series	 which	 was	 higher	 than	 others	 (52).	 They	 reasoned	 that	 delayed	
application	is	a	likely	causative	factor	as	the	most	common	organisms	cultured	
were	Staphylococcus	Aureus	and	Pseudomonas	(51).	Although	this	can	happen	
with	 autologous	 skin	 grafting,	 the	 studies	 performed	 are	 not	 methodically	











result,	 it	 was	 felt	 that	 skin	 substitutes	 consisting	 of	 dermal	 and	 epidermal	
components	in	one	sitting,	would	be	a	more	time	effective	approach	to	augment	




















despite	 their	 limitations,	 as	 their	 results	 are	 reproducible	 and	 undoubtedly	
beneficial	to	the	patient.	A	survey	conducted	by	Dunne	et	al	in	2015	across	14	













Girdner	 (54).	 Cadaveric	 skin	 is	 currently	 used	 as	 a	 temporary	 dressing	 on	 a	
freshly	 excised	 burn	 wound.	 It	 prevents	 evaporative	 losses,	 improves	
thermoregulation,	decreases	bacterial	 load	 in	contaminated	wounds	and	may	
provide	dermal	 regeneration	elements,	which	can	persist	once	 it	 is	 removed.	
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There	are	two	main	types	of	cadaveric	skin	allografts	based	on	the	method	of	
processing	 and	 storage:	 cryopreserved	 and	 glycerol	 preserved(55).	 In	 the	
context	 of	 large	 total	 body	 surface	 area	 burn	 excision	 in	 the	 acute	 phase,	 it	
provides	a	stimulus	for	the	release	of	growth	factors	and	cytokines	in	the	wound	
bed.	 It	also	 increases	 the	vascularity	with	enhanced	capillary	 ingrowth	of	 the	
wound	bed.	The	take	rate	of	skin	grafts	following	application	of	cadaveric	skin	
to	prepare	the	wound	bed	can	be	as	high	as	88.4%(55).		It	can	also	be	used	as	a	
definitive	 dressing	 in	 partial	 thickness	 burns,	 which	 is	 associated	 with	 less	
painful	 dressing	 changes.	 This	 is	 particularly	 important	 in	 the	 paediatric	
population	 as	 burns	 dressing	 changes	 are	 associated	 with	 physical	 and	
psychological	distress.	Its	use	however	in	this	population	has	been	superseded	






plastic	 surgery	 and	 burns	 units	 across	 the	 United	 Kingdom,	 there	 are	 still	
challenges	with	respect	to	its	supply	(57).		The	United	Kingdom	has	centralised	





have	 the	 advantage	 of	 low	 cost,	 prolonged	 shelf	 life,	 availability	 and	
convenience	particularly	 	when	allograft	 is	not	available	and	coverage	 is	only	
required	for	a	short	time	(58).	Furthermore	tissue	harvesting	from	the	deceased	
is	 a	 relatively	a	new	concept	 in	many	developing	 countries	as	 some	 religious	
beliefs	 can	 view	 this	 as	 mutilation	 of	 the	 body(59).	 Furthermore,	 despite	
rigorous	screening,	there	remains	the	risk	of	prion	disease	transmission.		
Having	said	this,	the	Euro	skin	bank,	established	by	that	name	in	1992,	formally	
the	 Dutch	 National	 skin	 bank,	 represents	 an	 efficient	 practice	 of	 harvesting,	
storing	 and	 providing	 glycerol	 preserved	 cadaveric	 skin(60).	 Glycerol	 is	
advantageous	 as	 it	 preserves	 the	 architecture	 of	 the	 matrix	 proteins,	 has	
antibacterial	 and	 antiviral	 properties	 and	 it	 is	 thought	 to	 diminish	
antigenicity(61).	Organization	is	the	key	to	the	skin	bank’s	success	as	it	is	hosted	
in	 its	own	 facility	 staffed	with	an	 independent	 team	of	 technicians,	 research,	
managerial	and	medical	personnel.	Additionally,	they	are	in	close	proximity	to	a	
hospital	 that	 treats	major	 burns	which	 allows	 for	 a	 feedback	mechanism	 on	
quality	control	and	assurance(60).	As	a	 result,	 the	uptake	and	use	of	glycerol	
preserved	 cadaveric	 skin	 became	 so	 popular	 in	 the	 early	 1990s,	 that	 the	
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healing.	 The	 centralisation	 of	 the	 skin	 bank	 in	 this	 way	 not	 only	 allows	 an	







thickness,	 turnover	 and	migration,	 hair	 distribution,	 dermal	 elastin	 structure	
and	collagen	macrostructure(62)(63).		
There	are	various	preparations	that	are	available	for	clinical	use	and	the	method	




the	 aldehyde	 preparation	 results	 in	 removal	 of	 the	 epidermis	 and	 dermal	
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appendages	 leaving	behind	a	sterile	dermal	acellular	matrix	 that	can	be	used	













and	micro-organisms	 temporarily,	 whilst	 donor	 sites	 are	 regenerating	 or	 the	
patient	is	being	physiologically	optimized	for	further	surgery.	Porcine	products	
form	 fibrin-collagen	 bonds	 with	 the	 underlying	 wound	 bed	 that	 allows	 the	
dressing	 to	 adhere	 readily.	 There	 is	 no	 vascularization	 or	 take	 in	 xenografts,	







Biobrane	 was	 developed	 in	 1980	 by	 Tavis(70).	 It	 has	 a	 bilaminar	 structure	
consisting	of	a	woven	nylon	membrane	coated	with	silicone	to	which	collagen	is	
chemically	bound.		It	aims	to	prevent	evaporative	fluid	losses	and	development	
of	 infection	when	used	as	a	dressing	 in	 superficial	partial	 thickness	burns.	 Its	
















Staphylococcal	 toxic	 shock	 syndrome	 after	 Biobrane	 use,	 which	 is	 a	 major	
morbidity	 especially	 in	 the	 paediatric	 population	 where	 this	 product	 is	








The	 main	 epidermal	 substitute	 that	 is	 clinically	 in	 use	 is	 cultured	 epithelial	
autografts	(CEA)(76).	These	are	used	primarily	as	an	adjunct	to	split	thickness	
grafts	 rather	 than	on	 its	own,	as	 it	 has	been	 reported	 to	provide	 suboptimal	
outcomes	 at	 a	 significant	 expense(77).	 Clinical	 take	 has	 been	 reported	 at	
45%(77).	They	can	be	used	over	widely	meshed	grafts	or	donor	sites	to	expedite	
healing.	 They	 can	 also	 be	 placed	 on	 dermal	 scaffolds	 eg	 Integra	 or	 dermal	
allograft	for	partial	thickness	defects	where	some	residual	dermis	will	allow	for	
	 72	




care	 to	 prevent	 fragmentation.	New	methods	 have	 since	 emerged	 to	 deliver	
these	 	 cells	 	 to	patients,	 in	 the	 form	of	 	 specialized	 carrier	dressings	 (78)and	
suspension	sprays(79).		
	
Cell	 suspensions	 contain	 basal	 keratinocytes,	 melanocytes	 and	 papillary	
fibroblasts.	 They	 avoid	 the	 use	 of	 Dispase,	 an	 enzyme	 used	 to	 release	 the	
epidermal	 sheets	 from	 culture,	 which	 removes	 surface	 proteins	 from	
keratinocytes,	 thereby	 reducing	 its	 adhesive	 potential(80).	 Furthermore	 sub-
confluent	cells	can	be	used	which	reduces	the	laboratory	processing	time	and	it	











terms	of	 living	cells	this	 is	the	most	commonly	and	frequently	used	project	 in	
routine	NHS	use	in	the	UK	to	the	best	of	our	knowledge.	
The	 proposed	 benefit	 of	 cultured	 keratinocytes	 is	 the	 potential	 to	 increase	
wound	 epithelization	 due	 to	 the	 presence	 of	 basal	 keratinocytes	 	 and	
transplantation	 of	 melanocytes																																																																																																																		
which	aims	to	maintain	the	colour	of	the	patient’s	skin	as	the	biopsy	to	source	
the	autologous	cells	 is	usually	 taken	 just	adjacent	 to	 the	defect(81).	Multiple	
studies	have	 investigated	 the	use	of	CEA	either	alone	or	 in	combination	with	
other	products	like	Integra.	When	CEA	on	their	own	are	applied	to	excised	burn	
wounds,	 take	 can	 be	 inconsistent.	 For	 example	 one	 case	 series	 reported	 an	
overall	take	of	80%	for	burns	with	a	mean	of	66%	TBSA(82).		Furthermore,	for	
burns	 larger	 than	80%	TBSA	 required	at	 least	 two	applications	of	CEA.	Other	
improved	outcomes	 included	 reducing	donor	 site	 scarring	when	 the	CEA	was	
applied	 to	 these	 areas(83).	 	 One	 of	 the	 fundamental	 problems	 of	 CEA,	 is	 its	





elements	 are	 left	 behind	 to	 full	 thickness	 burns	 that	 can	 extend	 beyond	 the	
dermis.	 It	 is	 no	 surprise	 that	 there	 are	 reports	 of	 better	 CEA	 take	 in	 partial	
thickness	 burns.	 However,	 in	 large	 TBSA	 full	 thickness	 injuries,	 it	 has	 been	
reported	that	there	was	60%	reduced	adherence	of	the	CEA	up	to	6	months	post	
application	whereby	 the	 sheets	were	dislodged	with	minimal	 shearing	 forces	
and	these	areas	simply	blistered	and	sloughed	off.	(84).	CEA	provides	epidermal	
cover,	skin	loss	in	large	burns,	of	which	this	application	is	most	used,	can	be	at	













A	 small	 sample	 of	 split	 thickness	 skin	 is	 obtained	 close	 to	 the	 area	 to	 be	
reconstructed	and	added	to	a	small	container	containing	an	enzyme	(porcine	
origin)	and	heated	for	about	15-	30	minutes	to	and	added	to	a	buffer	solution	to	








matrix	 from	 the	 skin	 sample	 and	 laid	 over	 an	 expansion	 ratio	 of	 80:1	 in	 an	
attempt	to	aid	epidermal	 regeneration	and	re-epithelization.	 It	has	also	been	
reported	to	treat	conditions	like	rhinophyma	and	congenital	melanocytic	naevi	
where	 in	 both	 these	 cases,	 post	 debridement,	 the	 dermal	 components	 are	
present	(86)(87).	A	study	by	Holmes	et	al	in	2018	comparing	the	use	of	ReCell	
combined	with	widely	meshed	 STS	 vs	 STGs	 alone	 revealed	 that	 donor	 areas	
harvested	combined	with	Re	Cell,	were	superior	in	terms	of	healing	at	weeks	1	
and	 2	 post	 op	 respectively	 compared	 to	 STSGs	 alone(88).	 This	 was	 to	 be	
expected	 as	 used	 thinner	 STSGs	 were	 used	 with	 the	 ReCell	 group	 than	 the	
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time	 to	 complete	 epithelization,	 postoperative	 pain	 and	 contractures	 (89).	
Procedure	time	was	found	to	be	significantly	longer	in	the	cases	that	used	ReCell	
versus	 skin	 grafting.	 Studies	 have	 also	 investigated	 the	 use	 of	 ReCell	 in	
combination	with	split	 skin	grafting	and	Biobrane(90)	however	 there	was	not	
enough	statistical	analysis	to	accurately	determine	whether	these	combinations	
conferred	 a	 worthwhile	 benefit.	 The	 National	 Institute	 of	 Clinical	 Excellence	
(NICE)	which	provides	recommendations	to	English	health	care	providers	on	use	
of	medicines	and	products	has	not	 supported	 routine	adoption	of	 the	use	of	














on	 the	other.	The	pore	size	 in	 the	biological	 layer	 ranges	 from	70-200	μm	to	
allow	 migration	 of	 fibroblasts	 and	 endothelial	 cells,	 which	 is	 needed	 for	
integration(94).	 The	 product	 is	 applied	 with	 the	 biological	 layer	 facing	 the	
wound	bed,	secured	at	the	edges	with	sutures	or	glue	and	dressed	to	facilitate	
regular	inspections.	The	collagen	layer	then	bio	integrates	with	the	wound	bed	






of	 the	 donor	 site	 (more	 thinly	 harvested	 than	 autograft	 alone),	 with	 faster	
healing	times(95).The	longest	published	series	using	Integra	reported	benefits	
such	as	over	80%	 take	 rates	with	no	 severe	hypertrophic	 scar	 formation	and	
excellent	 function	where	 it	has	been	used	over	 involved	 joints(96).	However,	








available),	 requiring	 a	 return	 to	 theatre	 and	 the	 biological	 layer	 contains	
products	of	animal	origin.	Furthermore,	it	is	quite	expensive	which	limits	its	use	















epidermal	 cells.	 It	 is	 thought	 that	 the	 combination	 of	 collagen	 and	 elastin	
promotes	vascularization	quicker	and	support	the	ingrowth	of	cells	and	vessels.	
Matriderm	is	used	in	the	management	of	burns	both	in	the	acute	and	chronic	
settings	 for	 burn	 scar	 contracture	 reconstruction.	 Studies	 have	 indicated	 it	







One	 of	 the	 most	 notable	 translated	 composite	 skin	 substitute	 material	 was	
performed	by	Boyce	and	colleagues.	This	consisted	of	creating	a	cultured	split	
skin	(CSS)	graft	in	the	laboratory	and	applying	it	on	debrided	wounds	pre-treated	
with	 allograft	which	 optimized	 vascularization.	 In	 later	 studies	 they	 replaced	
allograft	with	 Integra(100).	 	 A	 biopsy	 of	 the	 patient’s	 skin	was	 taken	 for	 cell	
culture	 and	 expansion	 to	 create	 an	 epidermal	 layer.	 The	 dermal	 analogue	
consisted	 of	 a	 bovine	 collagen-glycosaminoglycan	 (CAG)	 substrate.	 The	
epidermal	cells	once	expanded	were	inoculated	into	the	CAG	substrate	at	high	
	 80	
cellular	 density.	 These	 were	 cultured	 until	 keratinocyte	 stratification	 and	
confluence	 were	 found	 to	 be	 optimal	 as	 checked	 by	 light	 microscopy(101).	
Patients	with	>	50%	TBSA	burns	were	used	in	its	evaluation	and	it	was	compared	




pattern	which	 are	 common	when	 autologous	 split	 skin	 grafts	 are	 used(102).	
Furthermore,	it	was	reported	that	for	excessively	large	full	thickness	burns	(TBSA	
88%)	complete	coverage	was	achieved	using	Integra	and	CSS	by	55	days.	This	




in	 large	burns	 in	 a	 relatively	 timely	manner	 and	 the	 importance	of	 achieving	









This	was	 previously	 called	Graftskin	 and	 is	 another	 biological	 composite	 skin	
substitute	 consisting	 both	 of	 epidermal	 and	 dermal	 components(103).	 The	
dermal	aspect	is	mimicked	using	a	scaffold	consisting	of	bovine	type	I	collagen	
and	 human	 derived	 foreskin	 neonatal	 fibroblasts.	 The	 epidermal	 component	
consists	of	human	foreskin	derived	neonatal	epidermal	keratinocytes	that	are	
cultured	onto	the	dermal	scaffold	and	allowed	to	stratify	before	transferring	it	
onto	 the	 patient(104).	 Thus	 this	 is	 based	 on	 allogeneic	 cells	 which	 will	 not	




healing	 via	 secondary	 intention.	 In	 this	 case,	 it	 is	 reported	 that	 Apligraf	was	
associated	with	a	less	vascular	scar	and	a	better	cosmetic	appearance	than	those	
healing	by	secondary	intention(105).	Furthermore,	when	it	is	used	to	aid	donor	
site	wound	healing	 following	grafting	of	 large	burns,	 it	 is	associated	with	 less	
pain	when	compared	to	simple	polyurethane	films(106).	It	was	also	used	in	the	
reconstruction	 of	 small	 full	 thickness	 burn	 injuries	 where	 it	 was	 shown	 to	
expedite	wound	healing(107).	The	evidence	for	 its	successful	use	is	 limited	to	
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level	 IV	 and	 V	 clinical	 studies,	 with	 low	 patient	 numbers	 and	 no	 definitive	
comparison	to	the	clinical	gold	standard	which	is	an	autologous	skin	graft.		
Most	of	 its	advocated	clinical	use	 lies	 in	the	field	of	venous	and	diabetic	 foot	
ulcers	where	it	has	been	shown	to	be	a	cost	effective	option	in	the	long	term	
management	 of	 these	 chronic	 wounds	 as	 it	 offsets	 the	 need	 for	 continuous	
dressing	and	treatment	of	episodic	infections	due	to	its	associated	significantly	
shorter	 healing	 times	 when	 used(108)(109).	 This	 product	 has	 not	 gained	







Electrospun	 scaffolds	 have	 been	 at	 the	 forefront	 of	 tissue	 engineering	 with	
many	 uses	 in	 healthcare	 ranging	 from	 tissue	 regeneration	 to	 drug	 delivery	
systems.	Scaffolds	have	been	developed	in	almost	all	areas	where	there	is	lack	
of	 native	 tissue	 and	 current	 clinical	management	 does	 not	 yet	 yield	 optimal	
results	for	example	bone	replacement,	treatment	of	cleft	lip	and	palate	and	skin.	
Scaffolds	 can	 be	 synthetic	 or	 biological.	 Scaffolds	 fabricated	 using	
electrospinning	 have	 a	 wide	 variety	 of	 biomedical	 applications	 due	 to	 the	
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flexibility	in	mimicking	some	of	the	properties		of	the	native	tissue.	Networks	of	
both	 micro	 and	 nanofibres	 can	 be	 made	 separately,	 in	 layers;	 they	 can	 be	
templated	 or	 bioactive	 agents	 eg	 vitamin	 C(110)	 and	 anti-inflammatories	
(111)or	hormones	such	as	oestradiol	(112)can	be	delivered	from		the	fibres.	This	
results	in	a	range	of	scaffolds	consisting	of	various	orientations	of	fibre	size	and	










dissolved	 biodegradable	 polymers.	 	 The	 dissolved	 polymer	 is	 loaded	 into	 a	

















adjustable	 speeds	 that	 can	 further	 influence	 the	 properties	 of	 the	 fibres.	
Another	 commonly	 used	 speed	 was	 200	 rpm	 to	 create	 the	 initial	 trilayer	
electrospun	 scaffold	 architecture(114).	 The	 diameter	 of	 the	 fibres	 can	 be	
modified	by	changing	any	one	of	many	parameters	in	the	electrospinning	set	up	














These	 can	 be	 thought	 of	 as	 chemical	 compounds	 that	 have	 the	 ability	 to	


















required	 for	 the	 specific	 tissue	 application.	 Polymers	 used	 in	 biomedical	
applications	are	biodegradable	and	can	be	designed	to	stay	in	the	body	for	as	
long	 as	 it	 is	 needed	 and	 then	 disappear	 without	 the	 need	 for	 any	 surgical	
intervention	to	physically	remove	them.	Furthermore,	the	breakdown	products	
are	 non-toxic	 and	 excreted	 in	 a	 predictable	 fashion.	 These	 were	 initially	
developed	for	orthopaedic	applications	like	internal	fixation	of	bone	(116),	but	
have	 now	 extended	 to	 vascular	 stents(117),(118)	 and	 drug	 delivery	
systems(119).		
Synthetic,	hydrolytically	degrading	polymers	are	preferred	for	implants	or	drug	















which	 is	 needed	 for	 skin	 wound	 repair.	 Blackwood	 et	 al	 established	 that	 a	
copolymer	of	poly	(D,	L)	 lactide-co-glycolide	(PGLA)	at	a	75:25	ratio	of	PLA	to	
PGA	was	appropriate	for	use	in	human	dermal	replacement	as	it	supported	the	
migration	 and	 proliferation	 of	 keratinocytes	 and	 fibroblasts	 and	 facilitated	
collagen	production	and	deposition.	Additionally	it	did	not	undergo	necrosis	or	
encapsulation	and	degraded	by	50%	within	 three	months	when	 implanted	 in	
rats	(124).This	is	thought	to	be	physiologically	desirable	as	by	the	three-month	







In	 order	 to	 use	 electrospun	 scaffolds	 in	 biomedical	 applications,	 their	
mechanical	properties	need	to	be	assessed	to	determine	their	suitability.		The	
strength	and	deformability	of	the	fibres	must	match	as	closely	as	possible	the	
tissue	one	 is	 trying	to	replace.	This	 is	especially	 important	for	example	 in	the	
manufacturing	 of	 biosynthetic	 vascular	 grafts,	which	 are	 proposed	 for	 use	 in	
atherosclerotic	arteries.	Any	material	that	aims	to	replace	a	vessel,	must	match	
its	 physical	 and	 mechanical	 properties	 so	 as	 to	 avoid	 the	 disastrous	
consequences	 of	 graft	 failure	 e.g.	 aneurysm	 formation	 if	 the	 walls	 cannot	
withstand	the	blood	flow(125).		Furthermore,	as	most	electrospun	scaffolds	are	
populated	with	cells	and	then	cultured,	 it	 is	also	helpful	to	determine,	 if	post	
culture	 there	are	 any	effects	or	 changes	 to	 the	mechanical	 properties	of	 the	
scaffolds.		
Mechanical	properties	are	measured	using	a	uniaxial	tensile	test	(Figure	1.7)	or	































trilayers	 of	 polyhydroxybutyrate-co-valerate	 (PHBV)	 and	 PLA	 (114).	
Electrospinning	of	PHBV	results	in	nanofibres	that	are	useful	as	a	barrier	layer	
due	 to	 the	 small	 fibre	 and	 pore	 size	 between	 them.	 Scaffolds	 containing	
nanofibres	 facilitate	 cell	 adhesion,	 migration	 and	 proliferation,	 especially	
fibroblasts	 that	 assume	 a	 spindle-type	 shade	 in	 the	 neighbourhood	 of	 the	
nanofibres(128).		Furthermore	these	ultra-fine	fibres	have	similarities	with	the	
extra	 cellular	 matrix	 of	 natural	 tissue	 due	 to	 their	 porosity,	 fibre	 diameter	
orientation	and	mechanical	strength(129).	
Another	 technique	 employed	 to	 improve	 the	 topography	 of	 electrospun	
scaffolds	involves	the	use	of	conductive	templates	onto	which	fibers	are	spun	–	
this	 patterns	 the	 scaffolds	 thereby	 increasing	 the	 chances	 of	 cellular	
proliferation	(Figure	1.8)(130),(131).		
These	templated	scaffolds	have	already	been	developed	for		clinical	application	



























hydrophilic	 and	 negatively	 charged	 thus	 preventing	 absorption	 of	 molecules	
that	promote	thrombus	formation	(albumin	and	fibrinogen)	 in	scaffolds	to	be	





thereafter,	 it	 too	 can	 be	 functionalized	 onto	 scaffolds	 to	 increase	 potential	
neovascularization.	 This	 was	 demonstrated	 by	 Gigliobianco	 et	 al	 where	
electrospun	PLA	scaffolds	coated	with	alternative	 layers	of	polyethylenelmine	
(PEI)	and	heparin	showed	that	this	was	a	superior	technique	to	bind	to	VEGF	as	
compared	 to	 using	 PEI	 and	 Polyacrylic	 acid	 (PAC)	 alone.	 Furthermore	 these	
heparin-coated	scaffolds	were	 then	 implanted	 into	a	chick	chorionic	allantoic	




support	 cellular	 function.	 It	 is	 known	 that	 ascorbic	 acid	 is	 a	 cofactor	 for	 the	




that	 by	 producing	 ascorbic	 acid	 releasing	 scaffolds,	 collagen	 production	 is	
increased	significantly	when	they	are	seeded	with	fibroblasts	compared	to	those	
scaffolds	 without	 ascorbic	 acid(110).	 The	 ability	 to	 stimulate	 collagen	


















thereby	 tissue	 type	 that	 it	 aims	 to	 support.	 Furthermore,	 mixing	 polymers	
allowing	 it	 to	 provide	 support	 for,	 as	 long	 it	 is	 needed,	 can	 control	 its	
biodegradation.	 After	 this	 time	 period	 it	 is	 expected	 that	 the	 scaffold	 will	
degrade	into	physiological	by	products	that	are	easily	excreted	leaving	behind	
the	 patient’s	 native	 tissue,	 which	 has	 regenerated,	 similar	 to	 an	 absorbable	
suture	that	disappears	when	the	suture	line	has	healed.		Furthermore,	scaffolds	
can	 be	 textured	 and	moulded	 into	 different	 sizes	 and	 shapes	 to	 aid	 cellular	
















engineered	 skin.	One	 such	group	 successfully	used	poly[lactic	 acid-co-glycolic	
acid]	 (PLAGA)	 which	 produced	 appropriate	 electrospun	 scaffolds	 for	 skin	
replacement(138)	Other	groups	are	 trying	 to	 integrate	bioactive	 components	
like	 glycosaminoglycans	 (GAGs)	 (hyaluronan	 and	 chondroitin	 sulphate)	 into	














accepting	 of	 materials	 that	 come	 from	 commonly	 used	 bovine	 and	 porcine	
sources.	Electrospun	scaffolds	in	this	respect	are	desirable	materials	as	they	are	
biocompatible,	 synthetic	 and	 their	 chemical	 and	 physical	 structure	 can	 be	
altered	 to	match	key	 features	 that	are	 required	 in	skin	 reconstruction.	These	
include	prevention	of	 fluid	and	protein	 loss	 from	the	wound	bed,	 removal	of	
exudate,	inhibition	of	microbial	invasion	and	their	fibres	need	to	support	cellular	
attachment,	guide	endogenous	cells	 to	proliferate	and	remodel.	Both	natural	
and	 synthetic	 polymers	 have	 been	 used	 in	 the	 electrospinning	 process	 to	
produce	electrospun	scaffolds	for	skin	regeneration.		Improvements	have	been	
made	 to	 this	 technique	 by	 combining	 synthetic	 polymers	 that	 provide	 the	
mechanical	strength	of	the	scaffold	and	natural	polymers	like	gelatin,	chitosan	
and	 collagen	 to	 facilitate	 cellular	 attachment	 and	 migration.	 For	 example	
PCL/collagen	scaffolds(141)	and	PCL/chitosan(142)	have	shown	good	fibroblast	











fibrin.	 Fibrin	 are	 initially	 peptide	 monomers	 that	 are	 covalently	 cross	 linked	
though	the	action	of	factor	13	to	form	an	insoluble	polymerized	fibrin	clot(143).	
Fibrin	 is	 an	 essential	 component	 of	 the	 blood	 clot	 that	 has	 a	 central	 role	 in	
haemostasis.	 It	 has	 been	 used	 extensively	 as	 a	 biological	 polymer	 in	 tissue	








effect	 physiological	 tissue	 adhesive	 that	 is	 commercially	 available.	 The	
concentration	of	fibrinogen	and	thrombin	used	affects	the	structure	of	the	clot	





wound	 healing	 cells	 to	 cells	 like	 fibroblasts	 and	 keratinocytes	 and	 their	
associated	growth	factors.	Most	commercial	preparations	of	 fibrin	contain	an	
anti-fibrinolytic	component	to	slow	the	degradation	of	fibrin.	Fibrin	 is	used	in	



















This	 is	 advantageous	 as	 fibrin	 has	 been	 shown	 to	 stimulate	 the	migration	 of	
keratinocytes(146)	 and	 fibronectin	 which	 is	 a	 glycoprotein	 in	 fibrin	 does	
enhance	cellular	migration	during	wound	healing(147).		
For	 this	 thesis,	 the	 fibrin	used	 in	 the	experiments	act	 as	an	adhesive	 to	help	





fibrin	 to	 the	electrospinning	process	changes	 the	mechanical	 structure	of	 the	
electrospun	 scaffold	 which	 has	 already	 been	 established	 in	 the	 MacNeil	
laboratory	 for	 skin	 replacement.	 Moreover,	 by	 using	 fibrin	 on	 top	 of	 the	
































1. Evaluation	 of	 how	 a	 novel	 method	 for	 spinning	 a	 basement	 membrane	
substitute	can	encourage	epithelial-stromal	organisation.		
	
2. Investigation	 of	 whether	 the	 inclusion	 of	 features	 that	 approximate	 the	
dimensions	of	 rete	 ridges	will	 help	 in	 the	outgrowth	of	 epithelial	 cells	 into	
epithelial	cells	into	the	electrospun	scaffolds.	
	















	 	The	 aim	 of	 this	 project	 is	 to	 bring	 the	 use	 of	 a	 one	 stage	 reconstructive	
technique	using	tissue-engineered	scaffolds	closer	to	clinical	use.	This	promises	
to	be	a	viable	economical	alternative,	which	uses	the	patient’s	own	skin	in	the	
form	 of	 a	 biopsy,	 thereby	 avoiding	 the	 need	 to	 culture	 cells	 in	 the	 lab	 in	
combination	with	the	use	of	biodegradable	synthetic	FDA	approved	polymers,	
already	in	clinical	use,	free	from	products	of	animal	origin.		
This	 model	 of	 combining	 scaffolds	 with	 small	 tissue	 explants	 is	 clinically	
successful	in	the	treatment	of	scarred	corneas.	Ocular	disease	resulting	in	limbal	
stem	deficiency	results	 in	the	 inability	 to	use	corneal	 transplants.	A	biopsy	of	
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a	 small	 biopsy	 of	 the	 patient’s	 skin	 is	 minced	 into	 very	 fine	 explants	 and	
combined	with	electrospun	scaffolds	and	secured	onto	the	surgically	prepared	
wound	bed.		It	is	expected	that	fibroblasts	and	keratinocytes	will	migrate	along	
the	 fibres	 of	 the	 scaffold	 to	 enhance	 wound	 healing	 without	 the	 need	 for	
culturing	cells	in	a	laboratory	and	further	theatre	sessions.	The	current	project	
seeks	to	develop	this	further	through	the	development	of	more	sophisticated	




of	 haemostasis	 and	 used	 surgically	 as	 sealant.	 It	 can	 be	 prepared	 from	













































Ethical	 Permission	 was	 obtained	 from	 the	 NHS	 Health	 Research	 Authority,	





skin	 +/-	 subcutaneous	 fat	 that	would	 normally	 be	 incinerated.	 Patients	were	
consented	preoperatively	using	both	the	standard	Sheffield	Teaching	Hospitals	
Trust	consent	 form	in	addition	to	that	produced	by	Professor	Sheila	MacNeil,	








accordance	 with	 the	 General	 Medical	 Council’s	 (GMC)	 Good	 Medical	
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A	 Watson	 knife	 was	 procured	 from	 York	 Medical	 Technologies	 Limited	 and	
disposable	blades	were	obtained	from	Swann	Morton	Ltd,	Sheffield,	England.		
Skin	 was	 obtained	 in	 theatre	 from	 breast	 specimens	 (breast	 reductions	 or	
mastectomies)	or	brought	into	the	lab	for	harvesting	in	cases	of	free	flap	breast	
reconstruction.	 The	 method	 used	 at	 either	 site	 was	 the	 same.	 Skin	 was	
harvested	under	aseptic	conditions.	One	side,	the	specimen	was	secured	onto	a	










Aldrich,	Dorset,	UK).	All	 specimens	were	 then	 labelled	with	a	unique	number	
that	was	anonymous	and	not	traceable	to	the	patient.	The	skin	collected	was	
recorded	 in	a	human	 tissue	 log	with	 the	 following	details:	date	of	 collection,	
tissue	collected	and	person	collecting	 it.	All	authorized	users	 thereafter	were	











The	 following	 reagents	were	made	up	 in	 the	 lab	 for	use	 in	both	500mls	10%	
serum	Green’s	media	 and	 10%	 serum	 (Dulbecco’s	Modified	 Eagle’s	Medium,	
Sigma-Aldrich,	Dorset,	UK)	DMEM	respectively.		
• Penicillin/streptomycin	 (Sigma-Aldrich,	 Dorset,	 UK)	 consisted	 of	 10,000	
i.u/ml	 penicillin	 and	 10,000μg/ml	 Streptomycin.	 Final	 media	
concentration:	100	i.u/ml	penicillin	and	100	μg/ml	streptomycin	
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of	 human	 recombinant	 insulin	 was	 weighed	 out	 and	 to	 this	 25mls	 of	
0.01M	HCL	was	added	to	dissolve	the	powder.		225	ml	of	distilled	water	
was	 then	 added.	 It	 was	 then	 filtered	 to	 render	 it	 sterile.	 Final	 media	
concentration:	5μg/ml		












• Epidermal	 Growth	 Factor	 (Human	 recombinant)	 (EGF)	 (R&D	 systems,	
Biotechne):	20μl	foetal	calf	serum	was	added	to	2mls	acetic	acid	(10mM).	
1ml	of	this	was	added	to	a	vial	containing	200μg	EGF	powder	and	mixed	
to	 dissolve.	 25μl	 aliquots	 were	 used	 in	 making	 media.	 Final	 media	
concentration:	10μg/l	
• Cholera	 Toxin	 (Sigma-Aldrich,	 Dorset,	 UK):	 1mg	 Cholera	 Toxin	 was	
dissolved	 in	1.18ml	distilled	water.	0.1ml	of	 this	 solution	was	added	to	

















This	 was	 used	 for	 fibroblast	 culture	 and	 was	 made	 and	 stored	 in	 the	 same	
conditions	as	above	by	combining	 the	 following	 reagents:	440	mls	of	DMEM,	

























• Difco-Trypsin	 0.1%	 (w/v)	was	 prepared	 by	 adding	 0.5g	 of	Difco	 trypsin	
powder	(Difco,	West	Molesey,	Surrey,	UK)	to	0.5	g	D-glucose	and	500-μl	
phenol	red	and	topped	up	to	500mls	PBS.	The	pH	was	made	to	7.45	using	
2M	NaOH	 and	 sterilized	 by	 filtering.	 It	was	 stored	 and	 used	 in	 10	mls	
aliquots	for	cell	culture	purposes.		
• Collagenase	A	from	the	bacterium	Clostridium	histolyticum	was	made	by	
dissolving	 100mg	 collagenase	 A	 powder	 (Roche	 Laboratories,	 West	
Sussex,	U.K)	in	180mls	10%	serum	free	DMEM.	This	was	then	filtered	to	










of	 cryovials	 containing	 i3T3	 cells	 (irradiated	 with	 a	 dose	 of	 60	 Greys)	 were	
removed	from	the	liquid	nitrogen	dewar	and	placed	in	a	37°C	incubator	until	just	
thawing.	 The	 thawed	 cells	were	 transferred	 to	 a	 sterile	 30	ml	universal	 tube	
containing	10%	serum	Green’s	media.	This	was	then	centrifuged	at		1000	rpmfor	
five	 minutes.	 The	 supernatant	 was	 discarded	 and	 isolated	 cell	 pellet	 was	
resuspended	in	5mls	of	10%	serum	Green’s	Media.	The	cells	were	counted	using	
the	method	outlined	below.		If	needed	more	media	was	added	to	the	cells	to	
obtain	 a	 concentration	 of	 1	 x	 106	 cells/ml.	 	 An	 appropriate	 volume	 of	 cell	
suspension	 was	 then	 transferred	 to	 T75	 flasks	 to	 obtain	 a	 final	 seeding	
concentration	of	1	x106	cells.	Media	was	then	topped	up	to	10	mls	and	this	was	

















to	negate	the	action	of	 the	Difco-	 trypsin.	 If	 the	epidermis	did	not	peel	away	








these	surfaces	 the	PBS	became	 increasingly	cloudy.	 	A	sterile	Pasteur	pipette	











serum	 Green’s	 media	 was	 adjusted	 to	 give	 a	 final	 concentration	 of	 1	 x	 106	
















T75	 flasks	 were	 prepared.	 10%	 serum	 Green’s	 media,	 0.02%	 EDTA	 solution	
























10%	 serum	 Green’s	 media	 and	 placed	 in	 an	 incubator	 at	 37°C,	 humidified	
atmosphere	 5%	 CO2	 overnight.	 The	 cells	 were	 inspected	 daily	 under	 the	
microscope	and	 the	media	changed	every	2	 -3	days	 thereafter.	At	60	–	70	%	









dermis	 into	 a	 sterile	 petri-dish	 containing	 10mls	 of	 Collagenase	 A.	 This	 was	
incubated	 in	 37°C,	 humidified	 5%	 CO2	 overnight.	 The	 following	 day,	 the	
Collagenase	A/dermis	suspension	was	 inspected	to	ensure	that	all	 the	dermis	
was	digested	(cloudy	appearance).	Any	pieces	of	residual	dermis	were	removed	

























This	 was	 performed	 when	 the	 cells	 were	 60-70	 %	 confluent.	 The	 flasks	 of	



























either	 10%	 serum	 DMEM	 (for	 fibroblasts)	 or	 10%	 serum	 Green’s	 (for	
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Aesar,	USA)	 to	 30	mls	 of	 FCS	 to	make	 a	mixture	of	 10%	DMSO	 in	 FCS.	Once	
counted	the	cells	were	again	centrifuged	at	200g	(1000	rpm)	for	5	minutes.		The	










The	 required	numbers	of	vials	containing	cells	were	 removed	 from	the	 liquid	
nitrogen	left	to	defrost	at	room	temperature.	They	were	then	transferred	to	a	
sterile	30	ml	universal	tube	containing	10	mls	of	the	appropriate	pre-warmed	











These	 were	 then	 finely	 minced	 into	 approx.	 16-20	 squares.	 To	 this,	 a	 small	






This	was	obtained	 from	 the	Euro	 Skin	Bank,	 Zeestraat,	Netherlands.	 This	 is	 a	
national	 tissue	bank	 that	collects	and	preserves	split	 thickness	human	skin	 in	
glycerol.	Clinically	it	serves	as	a	temporary	wound	dressing	for	wounds.		


















again	 in	 sterile	 PBS	 to	 ensure	 that	 they	 were	 hydrated.	 Thickness	 was	 then	
measured	using	a	digital	micrometer.	Uniaxial	tensile	testing	was	performed	in	









For	 these	 experiments	 electrospun	 scaffolds	 were	 made	 from	 two	
biodegradable	 synthetic	 polymers.	 The	 first	 one	 was	
Polyhydroxybutyrate/Polyhydroxyvalerate	 (PHBV)	 12%	 biopolymer	
(Goodfellow,	Cambridge	limited,	Huntingdon,	England)	which	was	used	as	the	




wt.	 dichloromethane	 (solvent	 ratio	 88.8:11.1	 DCM-MeOH	 (Sigma-Aldrich,	
Dorset	 UK)	 was	 added	 using	 a	 glass	 pipette	 to	 obtain	 10	 %	 wt.	 /v	 PHBV.	 The	
mixture	was	placed	onto	a	stirrer	and	kept	overnight	for	dissolving.	10	%	wt.	/v	
PGLA	(75:25)	polymer	solutions	were	similarly	made	by	dissolving	the	polymer	










niches	 found	 in	 the	 dermal-epidermal	 junction	 of	 skin.	 These	 niches	 were	
templated	onto	the	scaffolds	using	a	textured	metal	collector	(Figure	2.1).	
The	first	polymer,	PHBV	was	loaded	into	4	x	5ml	syringes	(1	ml	in	each	syringe)	




















tips.	 The	 tip	of	 the	needle	was	now	positioned	17	 cm	 from	 the	 foil	wrapped	
copper	 collector.	 The	 syringe	 driver	 had	 the	 same	 settings	 as	 the	 PHBV.	 The	
syringe	driver	was	then	turned	on	followed	by	the	generator	set	at	17kV.	Once	
the	 syringes	 containing	 PGLA	 (75:25)	were	 empty,	 the	 scaffold	was	 removed	
from	 the	 collector,	 turned	 over	 and	 re-attached	 to	 the	 copper	 board	 using	
adhesive	tape.	A	further	4	x	5	ml	syringes	containing	PGLA	75:25	were	loaded	







































A:	 loaded	 syringes	 with	 polymer,	 B:	 Copper	 Plate	 fitted	 to	 the	 Blunt	 tipped	








	and	 316L	 stainless	 steel.	 The	 plates	 were	made	 using	 a	 range	 of	 niche	 like	






















used	 in	 the	 laboratory	 to	 conduct	 this	 test	was	 a	 uniaxial	 tensiometer	 (Bose	








































defrosted	 in	 a	 water	 bath	 slowly	 over	 2	 hours	 until	 they	 were	 at	 room	
temperature.	Depending	on	the	concentration	of	fibrinogen	and	thrombin	being	


















ring	 and	 these	were	 incubated	at	 37°C,	 humidified	5%	CO2	for	 48	hours.	 The	
constructs	 were	 then	 removed	 from	 the	 incubator	 and	 the	 presence	 of	




labelled	keratinocytes	CMTPX	were	now	seeded	 into	 the	centre	of	 the	metal	
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rings.	 For	 this	 3x	 105	 keratinocytes	 were	 used	 between	 passage	 one	 to	 four	
suspended	in	0.5mls	of	10%	serum	Green’s	media.	2mls	of	Green’s	media	was	
then	added	outside	 the	 ring	 and	 this	 construct	was	 again	 incubated	at	37°C,	
humidified	5%	CO2	for	48	hours.	At	the	end	of	this	time,	the	6-well	plates	were	
removed	 from	 the	 incubator	 and	 the	 presence	 of	 both	 keratinocytes	 and	























into	 15	 x15	 mm2	 pieces.	 These	 were	 placed	 into	 6	 well	 plates	 followed	 by	
stainless	 steel	metal	 rings	placed	on	 top.	 To	 this,	 1x105	CMFDA	 fluorescently	
labelled	fibroblasts	(between	passage	4	to	9)	were	placed	in	the	centre	of	the	
metal	ring	suspended	in	0.5mls	of	10%	serum	DMEM.	2	mls	of	DMEM	was	used	






and	 fluorescently	 labelled	 CMTPX	 keratinocytes	 were	 now	 seeded	 into	 the	























liquid	 interface	 using	 the	 metal	 grids	 to	 support	 the	 skin	 explant	 seeded	








into	 15	 x15	 mm2	 pieces.	 These	 were	 placed	 into	 6	 well	 plates	 to	 this,	 the	
prepared	skin	explants,	suspended	in	0.5	mls	of	10%	serum	Green’s	Media	was	








































media	 was	 added	 to	 the	 centre	 of	 the	 scaffold.	 Another	 layer	 of	 trilayer	


















into	 15	 x15	 mm2	 pieces.	 These	 were	 placed	 into	 6	 well	 plates	 followed	 by	
stainless	 steel	metal	 rings	placed	on	 top.	 To	 this,	 1x105	CMFDA	 fluorescently	
labelled	fibroblasts	(between	passage	4	to	9)	were	placed	in	the	centre	of	the	
metal	ring	suspended	in	0.5mls	of	10%	serum	DMEM.	2	mls	of	DMEM	was	used	





















CMFDA	 and	 CMTPX	 (Invitrogen,	 USA)	 were	 used	 to	 stain	 fibroblasts	 and	
keratinocytes	respectively	to	ensure	that	they	were	present	on	scaffolds	before	
they	 were	 raised	 to	 an	 air	 liquid	 interface.	 These	 are	 non-toxic	 probes	 that	
monitor	 cell	 movement,	 location	 and	 proliferation.	 	 They	 cross	 the	 cell	
membrane	 and	 stay	 within	 that	 cell	 for	 several	 daughter	 generations.	 They	
display	 florescence	 for	 at	 least	 72	hours	 to	 a	maximum	of	 7days.	 Fibroblasts	
were	stained	with	CellTracker	green.	Flasks	containing	fibroblasts	were	removed	














which	 was	 the	 number	 used	 for	 seeding	 onto	 scaffolds.	 The	 labelling	 of	
keratinocytes	followed	the	same	method.	CMTPX	was	used	at	a	concentration	
of	 10mM.	 The	 cells	 once	 labelled	 were	 harvested	 by	 the	 same	method	 and	
resuspended	in	the	required	amount	of	serum	10%	Green’s	media	to	ensure	that	
a	concentration	of	3	x105	cells	was	present	in	0.5	mls	of	media.	Once	seeded	the	
cells	 could	were	 imaged	 in	Olympus	 IX73	 Epifluroscent	Microscope	 (KeyMed	



















time,	 it	was	usual	 to	observe	some	colour	change	 in	 the	samples,	confirming	
cellular	viability.		200µl	of	dye	from	each	sample	was	pipetted	into	a	labelled	96	
well	 plate.	 They	were	 then	 read	 at	 570nm	 (manufacturer’s	 instructions)	 in	 a	
colorimetric	plate	reader	(BIOTEK,	NorthStar	Scientific	LTD,	Leeds,	UK).	This	was	


































UK)	 is	 a	 blue	 fluorescent	 stain	 that	 preferentially	 binds	 to	 nuclear	DNA.	 This	
produces	 a	 x	 20-fluorescence	 enhancement	 once	 bound	 to	 the	 DNA.	 It	






added	 to	 each	 construct	 just	 enough	 to	 cover	 it	 completely.	 It	 was	 then	
incubated	at	37°C,	in	a	humidified	atmosphere	of	5%	CO2	for	45	minutes.	The	








known	stain	 that	 is	used	 in	 collagen	histochemistry.	 It	binds	 to	and	 stains	all	
forms	of	collagen	fibrils	thereby	quantifying	the	amount	of	collagen	in	a	given	
area	of	the	construct.		0.1%	Sirius	red	stain	(Direct	red	80,	Sigma-Aldrich,	Dorset,	
UK)	 was	 prepared	 by	 weighing	 out	 the	 desired	 quantity	 and	 adding	 it	 to	





covered	 by	 the	 stain.	 They	 were	 placed	 onto	 a	 shaking	 platform	 and	 left	
overnight.	The	following	day,	the	constructs	were	washed	at	least	three	times	
in	distilled	water	to	remove	any	excess	stain.	They	were	then	left	to	air	dry	in	a	
laminar	 flow	 hood	 for	 48	 hours.	 Each	 construct	 was	 weighed	 and	 this	 was	
recorded.	Following	this	3mls	of	0.2M	NaOH:	Methanol	1:1	solution	was	added	











Samples	after	being	 fixed	 in	3.7%	 formaldehyde	were	 cryopreserved	prior	 to	
staining	 with	 Carazzi’s	 Haematoxylin	 and	 Eosin	 Staining.	 This	 method	 was	
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chosen,	 as	 it	 does	not	 result	 in	 destruction	of	 the	 scaffold	 compared	 to	wax	
embedding.	 These	 stains	 were	 chosen	 to	 highlight	 the	 cellular	 architecture/	
location	 within	 the	 scaffold.	 Haematoxylin	 is	 a	 dark	 blue/violet	 stain	 that	 is	
alkaline	in	nature	and	stains	cellular	nuclei	blue.	Eosin	is	a	pink	acidic	stain	that	
binds	 to	 cytoplasmic	 structures	 resulting	 in	 shades	 of	 red,	 pink	 and	 orange.	
Together	they	give	an	indication	of	the	location	of	cells	within	the	scaffold	and	







embedded	 with	 Optimal	 Cutting	 Temperature	 O.C.T	 TM	 (Tissue-Tek®	 4583,	
Sakura	Finetek,	Netherlands,	Europe)	compound.		
A	 pair	 of	metal	 forceps	was	 used	 to	 gently	 and	 slowly	 submerge	 the	 plastic	
cassette	in	liquid	nitrogen	(-197°C).	Once	the	sample	was	completely	frozen,	it	
was	 removed	 from	the	 liquid	nitrogen	and	 the	plastic	 cassette	very	gently.	A	
sterile	No.	 22	blade	was	used	 to	 cut	 the	 sample	 in	half.	 It	was	 then	 fixed	 to	
mounting	device	 the	O.C.T	 as	 an	 adhesive	 and	 left	 to	 solidify	 in	 the	 cryostat	
(Leica	CM1860	U.V,	Leica	Biosystems,	Germany).	The	sample	was	then	sectioned	
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stained	with	 eosin	 (Sigma-Aldrich,	 Dorset,	 UK)	 for	 five	minutes.	 The	 samples	
were	 then	washed	 in	 tap	 water	 again	 for	 1.5	minutes	 and	 then	 dehydrated	
through	70%	alcohol	(IMS;	Industrial	Methylated	Spirit,	Fisher	Scientific,	UK	Ltd.)	
by	dunking.	This	was	followed	by	100%	alcohol	for	30	seconds	and	finally,	they	
were	 cleaned	 in	 two	 changes	 of	 xylene	 (Fisher	 Scientific,	 UK	 Ltd)	 lasting	 one	
minute	each.	They	were	then	mounted	with	a	coverslip	using	a	DPX	mounting	
medium	(Fisher	Scientific,	UK	Ltd.)	and	left	to	air-dry	overnight.	The	following	
day	 images	 were	 taken	 of	 each	 slide	 using	 a	 light	 microscope:	 Motic	 B5	
Professional	and	the	software	used	for	analysis	was	Motek	Images	Advanced	3.2	
(Motek	 CME	 group	 ltd).	 Scale	 bars	 and	 final	 adjustment	 of	 the	 images	were	






Electrospun	 scaffold	 cultured	 with	 isolated	 cells	 and	 co-culture	 with	 skin	




75:25	 electrospun	 scaffolds	 that	 were	 cultured	 with	 isolated	 fibroblasts	 and	
keratinocytes	for	14	days	at	air	liquid	interface	were	fixed	in	3.7%	formaldehyde	
for	 at	 least	 30	minutes.	 They	were	 then	 cryopreserved	 using	 the	method	 as	
outlined	 above.	 Slices	 of	 7	 μm	 were	 made	 onto	 glass	 slides	 and	 left	 to	 dry	
overnight.	Immunostaining	was	also	performed	on	fixed	14	day	samples	where	
fibroblasts	were	 used	 to	 culture	 the	 templated	 trilayer	 electrospun	 scaffolds	
before	adding	skin	explants.	Due	to	the	3d	nature	of	these	scaffolds,	we	elected	
to	 immunostain	 the	 entire	 fixed	 sample	 followed	 by	 confocal	microscopy	 to	





with	 Triton	 X100	 (0.25%)	 for	 thirty	 minutes.	 After	 three	 washes	 of	 PBS,	
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quenching	was	performed	using	ammonium	chloride	(50mM)	for	ten	minutes.	
This	 was	 followed	 by	 adding	 fish	 gelatin	 (0.2%)	 as	 a	 blocking	 buffer	 for	 30	
minutes.	Samples	were	then	incubated	overnight	using	the	following	dilutions:		
	







• Collagen	 IV	 (Alexa	 Fluor	 488,	 e	 Bioscience,	 Thermofisher	 Scientific,	
Renfrew);	stock	0.5mg/ml	(conjugated).	Dilution	used	was	1	in	100.		
The	 following	day	 samples	were	washed	 three	 times	with	PBS	and	DAPI	was	





























2	 mL	 cacodylate	 buffer	 added	 and	 incubated	 for	 15	 min.	 Subsequently	 the	

















































































thickness	 skin	 as	 a	 one	 stage	 approach	 to	 full	 thickness	 skin	 defect	
reconstruction.	The	scaffold	is	designed	as	a	trilayer,	templated	membrane	like	
structure	with	 the	aim	of	encouraging	 fibroblast	entry	 into	 the	 lower	dermal	
layer	and	keratinocyte	production	of	an	epithelial	barrier	layer	separated	by	a	




The	basement	membrane	 to	 recap,	 is	 a	 thin	 layer	of	 specialized	extracellular	
matrix	onto	which	the	epidermis	is	attached.		It	links	the	epidermis	to	the	dermis	
and	 provides	 a	 barrier	 against	 epidermal	 migration(4).	 It	 is	 morphologically	
distinguished	into	four	layers:	the	plasma	membrane	of	the	basal	keratinocytes;	
lamina	 lucida;	 lamina	densa	and	 sublamina	densa.	 These	 layers	 augment	 the	
keratinocyte	to	dermis	attachment(5).	The	 lamina	densa	provides	mechanical	
strength	and	the	middle	 layer	 that	 forms	a	sheet	 like	structure	comprising	of	







range	 from	 50-400	 micrometres	 in	 width	 and	 50-200	 micrometres	 in	
depth(10),(11)	Epidermal	stem	cells	lie	in	specific	locations	relative	to	the	rete	
ridges	depending	on	their	location	in	the	body.	The	rete	ridges	are	an	important	
feature	 in	 the	 topography	 of	 the	 dermal-epidermal	 junction.	 It	 provides	
structural	integrity	for	the	epidermal-dermal	interface	and	defines	the	cellular	





of	biodegradable	PGLA	 (75:2%)	separated	by	a	very	 thin	 layer	of	nanofibrous	
PHBV.	The	latter	was	designed	so	that	cells	could	attach	to	these	fibres	but	the	









Figure	 3.1:	 Cartoon	 demonstrating	 structure	 of	 the	 templated	 trilayer	 of	
nanoporous	PHBV	between	two	layers	of	microporous	electrospun	fibres.				
	
PGLA	 (75:25)	 fibres	 were	 spun	 to	 be	 microfibres	 with	 relatively	 large	 pores	








(α-hydroxy	 esters).	 These	 polymers	 degrade	 via	 hydrolysis	 through	 de-
esterification.	 Under	 physiological	 conditions	 PGA	 is	 a	 rigid	 thermoplastic	
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during	 a	 second	 stage	 of	 fermentation.	Once	 the	 polymer	 is	made	 it	 is	 then	
separated	from	bacterial	cells	using	solvent	extraction	after	breaking	down	the	
bacterial	 cell	 wall(153).	 PHBV	 is	 more	 stable	 than	 polyesters	 and	 is	 more	




membrane	because	of	 its	biocompatibility,	 its	ability	 to	be	 reproducibly	 spun	
into	nano	fibres	and	it's	known	route	of	breakdown.	It	provides	a	large	surface	
area	of	nanofibres	for	extra	cellular	matrix	deposition	and	degrades	at	a	slower	
rate	 than	 PGLA,	 which	 provides	 a	 small	 amount	 of	 additional	 support	 for	
proliferating	cells	during	the	remodelling	phase	of	wound	healing.		
Electrospinning	is	one	of	several	methods	that	are	used	to	produce	porous	3D	
biodegradable	 scaffolds	 for	 tissue-engineering	 applications.	Other	 fabrication	
techniques	have	been	well	described.	These	can	be	divided	into	those	that	use	
porogens	in	biomaterials	(solvent	casting,	particulate	leaching,	gas	foaming	and	
freeze-drying	 and	 phase	 separation),	 solid	 free-form	 or	 rapid	 prototyping	
technologies	(selective	 laser	sintering,	stereolithography	and	3D	printing)	and	
techniques	that	develop	woven	and	non-woven	fibres	(use	of	thermal	energy	or	
adhesives	 to	 result	 in	 a	 porous	 fibrous	 network)(156).	 Electrospinning	 is	 our	









































underlying	 architecture	 is	 of	 great	 importance.	 	 Scaffolds	 should	 possess	 an	













ligands	 are	 often	 not	 present	 in	 scaffolds	 that	 are	 made	 from	 completely	
synthetic	substances.	These	 ligands	can	be	 incorporated	 into	the	scaffolds	by	
means	 of	 protein	 adsorption,	 however	 even	 if	 they	 are	 not	 deliberately	
incorporated	once	a	biomaterial	comes	into	contact	with	any	biological	fluid	eg	
blood	or	tissue	fluid,	proteins	-primarily	fibronectin	-will	begin	to	adhere	to	the	




















be	populated	with	 cells	 that	 are	present	 in	 the	 tissue	 that	 they	are	 trying	 to	
replace.	 This	 is	 so	 that	 the	 cells	 can	 proliferate	 and	deposit	 the	 extracellular	
matrix	that	will	allow	structure	to	effectively	regenerate	and	reform.	These	cells	
most	 commonly	 autologous	 (from	 the	 patient)	 or	 less	 commonly	 allogeneic	
(sourced	 from	 donor	 patients).	 When	 cells	 are	 sourced	 from	 the	 patient	
themselves,	 they	 need	 to	 be	 cultured	 onto	 the	 scaffolds	 until	 they	 become	
suitable	 for	 implantation.	 This	 requires	 time,	 clean	 room	 facilities	 and	 the	
expertise	to	undertake	this	process.		
As	a	result,	although	this	approach	has	been	clinically	successful	even	within	this	
group	 (78)	 uptake	 of	 these	 autologous	 therapies	 has	 not	 been	 extensive.	
Furthermore	using	biomaterials	that	require	animal	sources	either	as	part	of	the	
dermal	scaffold	eg	porcine	or	bovine	collagen	or	in	the	process	of	culturing	cells	

















is	 a	 continuation	 of	 the	 work	 by	 the	 MacNeil	 group	 in	 the	 field	 of	 skin	
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regeneration.	Foundation	work	performed	by	Blackwood	et	al	compared	PLLA,	
PGLA	 50:50,	 PGLA	 75:25	 and	 PGLA	 85:15.	 	 In	 vitro	 degradation	 studies	
performed	 here	 revealed	 that	 the	 PLLA	 degraded	 the	 slowest	 with	 it	 being	
largely	intact	after	one	year	and	the	PGLA	50:50	degraded	the	fastest	within	2	
weeks(124).	Given	that	a	healing	dermal	wound	has	most	of	its	tensile	strength	
between	60-90	days,	 it	would	be	desirable	 for	 the	 scaffold	 to	be	 structurally	
intact	for	this	period	of	time.	This	was	found	to	be	the	case	for	the	PGLA	75:25,	
which	lost	half	 its	strength	at	the	3-month	mark.	As	a	result,	PGLA	75:25	was	







membrane	 that	 would	 provide	 a	 framework	 around	 which	 cells	 could	 be	
stimulated	 to	produce	an	extracellular	matrix.	The	polymer	chosen	 for	 this	 is	
PHBV,	 which	 produced	 a	 scaffold	 which	 with	 pores	 large	 enough	 to	 allow	
fibroblasts	 to	 cross	 into	 the	 layer	 intending	 to	be	 the	dermis	 and	 later	 allow	
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interface	 is	 flat25.	 The	 height	 and	 overall	 dimensions	 of	 the	 rete	 ridges	 vary	
according	 to	 skin	 location	 on	 the	 body,	 age,	 and	 any	 acquired	 or	 congenital	
proliferative	disorders.	For	example,	the	height	of	the	rete	ridges	declines	as	we	
age(169)	and	increases	in	disorders	which	as	psoriasis	which	are	associated	with	
high	 epidermal	 turnover(170).	 Furthermore,	 the	 concentration	 of	 rete	 ridges	
varies	depending	on	the	anatomical	location	the	skin	that	is	being	assessed.	The	







superficial	 and	 closest	 to	 the	 skin	 surface(13).	 	 Previous	 products	 that	 have	




However,	 these	materials	 require	 cultured	 cells	which	 demand	 the	 time	 and	
facilities	for	cells	to	become	confluent	before	transfer.		









sheet	 to	 the	 underlying	 wound	 bed(171).	 Moreover,	 when	 keratinocytes	
achieve	confluence	they	rapidly	become	differentiated	cells	which	is	associated	







corneal	 regeneration	 to	 provide	 these	 stem	 cell	 niches	 –it	 was	 felt	 that	 this	
concept	could	be	applied	to	a	potential	dermal	analogue29.		
There	 is	 little	 data	 on	 the	 significance	 of	 the	 rete	 ridges	 as	 firstly	 they	 vary	
significantly	 between	 individuals	 and	 also	 between	 the	 anatomical	 area	 that	
they	have	been	taken	from.	Furthermore,	the	most	used	animal	model	for	skin	
research,	the	mouse,	has	no	rete	ridges.	Tissue	engineered	skin	made	using	the	





various	 adjuncts	 to	 the	 electrospinning	 process	 eg	 plasma	 treatment	 and	




opposed	 to	 one	 would	 increase	 the	 capacity	 of	 cells	 to	 be	 loaded	 into	 the	




migration,	 adhesion	 and	 secretion	 of	 collagen(176).	 Poly	 (L-lactic	 acid)-co-
poly(ε-caprolactone)	 (PLACL)	 and	 PLACL/gelatin	 complexes	 were	 made	 and	
plasma	 treated	 to	 improve	 their	 hydrophilic	 properties.	 After	 seeding	 these	






dermal,	 basement	 membrane	 and	 epidermal	 layers	 which	 maintained	 their	
structure	even	after	seeding	with	keratinocytes	and	fibroblasts.		
Our	scaffolds	are	novel	in	that	we	are	evaluating	the	incorporation	of	features	
of	 the	 fine	micro	 topography	of	 the	 skin	 like	basement	membranes	and	 rete	
ridges	 on	 cellular	 attachment,	 proliferation	 and	 migration.	 Moreover,	 the	
methods	of	production	of	these	scaffolds	are	easily	reproducible	and	convertible	
to	 small	 scale	 manufacturing	 for	 clinical	 applications.	 The	 methodology	 of	
producing	 templated	 scaffolds	 was	 recently	 published	 from	 the	 MacNeil	





























































This	difference	 is	expected	and	reflects	 the	design	of	 the	scaffolds.	The	PGLA	







Scaffolds	 with	 pore	 sizes	 that	 are	 <	 200	 µm	 facilitate	 the	 development	 of	
vascular	networks	with	 small	 vessels	at	high	density	and	shallow	penetration	
which	is	suitable	for	skin	substitutes	as	they	are	relatively	thin	compared	to	solid	

















of	 the	material	 during	 this	 linear	 slope	 is	 known	 as	 elastic	 deformation.	 The	
material	will	recoil	to	its	original	size	once	the	force	stops.	YM	is	the	first	linear	
slope	when	a	material	is	stretched	which	is	obtained	from	a	stress	strain	plot.	It	




the	 stiffer	 the	 material.	 Once	 this	 portion	 of	 the	 curve	 is	 past,	 all	 further	
elongation	observed	is	plastic	deformation.		Another	parameter	often	measured	
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is	 the	Ultimate	 tensile	 strength	 (UTS)	which	 is	 the	maximum	 strength	 of	 the	
material	 and	 the	 strain	 at	 ultimate	 tensile	 strength	 which	 is	 the	 maximum	
elongation	of	the	material	before	it	starts	to	snap.		





































































































































The	 non-templated	 trilayer	 scaffolds	 exhibited	 a	 significantly	 higher	 Young’s	
Modulus	 compared	 to	 monolayer	 PGLA	 (75:25),	 skin	 and	 Euroskin,	 which	





























































strength	 compared	 to	 templated	 scaffolds,	 fresh	 skin	 and	 Euroskin	 but	 not	
significantly	 different	 to	 monolayer	 PGLA	 (75:25)	 scaffolds.	 	 The	 templated	
scaffolds	had	similar	tensile	properties	to	skin	and	Euroskin	apart	from	Ultimate	








The	 middle	 layer	 of	 our	 electrospun	 scaffolds	 are	 templated,	 to	 mimic	 the	
undulations	present	in	the	interface	between	the	dermis	and	epidermis.	These	































to	clinical	 translation.	 Inorganic	polymers	are	attractive	as	 they	are	 inert	and	
non-reactive	with	predictable	breakdown	products	that	are	excreted	in	known	
physiological	 pathways.	 However,	 failure	 to	 develop	 and	 support	 a	 vascular	
system	will	result	in	failure	of	the	material	to	integrate	into	the	patient’s	own	
tissues.	As	a	result,	a	lot	of	research	has	focussed	on	increasing	the	angiogenic	


































existing	 vessel	 growth	 by	
endothelial	 cell	
proliferation	
	 VEGF	 and	 Heparin	
(136)	





















factors	 to	 stimulate	 blood	
vessel	ingrowth		
	 Ascorbic	Acid	(110)	 Co	 factor	 in	 collagen	 cross	
linking	 –	 thought	 to	
increase	 collagen	 which	 in	
turn	increases	the	ingrowth	
of	 blood	 vessels	 into	
scaffolds		

































to	 enhance	 their	 vasculogenesis.	 Several	 such	 approaches	 have	 been	
investigated	 in	 the	 MacNeil	 group.	 One	 such	 is	 the	 addition	 of	 estradiol	 to	
electrospun	 scaffolds.	 This	was	 investigated	by	Mangir	 and	 colleagues	where	
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they	used	PLA	containing	various	concentrations	of	oestradiol	and	evaluated	its	
angiogenic	 potential	 using	 a	 chick	 chorionic	 membrane	 assay(112).	 Their	





clinical	effects	of	 this	 is	 yet	unknown.	 	 	Another	 strategy	 investigated	adding	
ascorbic	acid	in	two	forms	l-ascorbic	acid	(AA)	and	ascorbate-2-phopshate	(A2P)	
to	 PLA	 scaffolds.	 This	 resulted	 in	 an	 increase	 in	 collagen	 production	 by	
fibroblasts(110).	 Although	 ascorbic	 acid	 is	 not	 a	 hormone	 and	 a	 vitamin,	 its	
proposed	use	as	part	of	a	scaffold	is	not	what	it	 is	 licensed	for	 in	humans	i.e.	
topical	and	oral,	as	a	result,	this	would	also	have	to	be		approved	before	being	
allowed	 into	 the	clinic.	Other	strategies	 include	the	addition	of	products	 that	
indirectly	 increases	 scaffold	vascularity.	For	example,	heparin	when	added	 to	
scaffolds	 stimulate	 the	 formation	 of	 new	 blood	 vessels.	 In	 order	 to	 use	 this	
property	of	heparin	on	scaffolds	efficiently,	chemicals	like	chitosan	are	added	to	
the	scaffold	used	to	increase	its		heparin	binding	capacity	5150.		
Our	model	did	not	 include	any	additives	hormonal	or	otherwise	 to	 stimulate	
neovascularization	specifically	as	ultimately	this	would	have	to	undergo	rigorous	
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adverse	 effects	 on	 the	 physiology	 of	 the	 patient.	 Also	 there	 is	 a	 need	 to	
demonstrate	that	this	is	significantly	better	than	the	current	materials	that	are	
being	used	to	tackle	the	clinical	problem	in	question.		
Vascularization	 is	 essential	 for	 any	wound	 to	 heal,	 however	 the	 skin	 has	 the	
ability	 to	 revascularize	 as	 a	 part	 of	 wound	 healing	 process	 given	 the	 right	
conditions	 (free	 of	 infection	 and	 the	 absence	 of	 excessive	 inflammation)	 are	
met.	This	is	because	signalling	proteins	are	concentrated	at	the	wound	edges,	
which	act	as	a	strong	drive	 for	endothelial	cells	 to	migrate	across	 the	wound	











groups	 have	 published	 for	 optimizing	 tissue	 engineered	 dermal	 scaffolds.	
Furthermore,	we	have	outlined	the	properties	both	essential	and	desirable	of	a	
dermal	scaffold	for	clinical	use	and	the	strategies	used	to	vascularize	scaffolds.	





























cellular	 phenotypes.	 The	 main	 constituents	 of	 all	 basement	 membranes	 are	
collagen	 IV	 and	 laminin.	 These	 are	 connected	 by	 nidogens	 (sulphated	
monomeric	glycoproteins).	Cells	are	connected	to	the	basement	membrane	via	
glycoprotein	 integrin	 receptors.	 Collagen	 type	 IV	 is	 the	 most	 widespread	
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basement	 membrane	 component,	 its	 structure	 and	 arrangement	 confers	
mechanical	stability	(196)(197).	Laminins	(several	heterotrimeric	forms:	laminin	
1	 to	 7)	 also	 make	 up	 a	 significant	 proportion	 of	 the	 basement	 membrane.	
Proteoglycans	are	another	important	basement	membrane	constituent	of	which	
perlecan	is	the	most	abundant	(198).			
These	proteins	allow	 the	membrane	 to	adjust	 function	at	 specific	anatomical	
sites.	For	example,	thin,	continuous,	extended	sheets	of	basement	membrane	
that	 maintain	 integrity	 and	 stability	 are	 needed	 over	 long	 distances	 in	 the	
vascular	system.		Additionally,	sufficient	mechanical	stability	is	needed	to	resist	









fibrils,	 anchoring	 the	 basement	 membrane	 to	 the	 underlying	 dermis.	 Both	
keratinocytes	 and	 fibroblasts	 contribute	 to	 the	 formation	 of	 the	 basement	
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membrane	 in	 the	 skin(201).	 The	 basement	 membrane	 and	 the	 underlying	
dermis	regulate	keratinocyte	growth	and	terminal	differentiation,	and	thereby	
influence	 the	 structure	 of	 the	 overlying	 epidermis	 and	 its	 crucial	 barrier	











culture(204).	 Skin	 has	 two	main	 layers	 separated	 by	 a	 specialized	 basement	
membrane.	It	would	be	desirable	to	create	a	scaffold	which	has	the	capacity	to	
support	 different	 cells	 to	 proliferate	 and	 migrate	 and	 simultaneously	
communicate	with	each	other	in	order	to	function	as	a	unit.		




two	 different	 polymers	 in	 three	 distinct	 layers	 thereby	 creating	 a	 trilayer	
electrospun	 scaffold.	 The	 PHBV	 or	 the	 basement	 membrane	 mimic	 will	 be	


































but	 still	 be	 porous	 enough	 to	 allow	 communication	 via	 chemical	 signalling	
between	 the	 two	 cell	 types(126).	 This	 is	 essential	 as	 the	 structure	 of	 the	
epidermis	 is	dependent	on	the	signalling	 factors	produced	by	 the	cells	of	 the	
epidermis	and	the	dermis	in	addition	to	the	underlying	basement	membrane.		
PGLA	75:25	was	chosen	based	on	previous	work	 that	aimed	at	establishing	a	
suitable	 polymer	 that	 would	 sustain	 the	 attachment	 and	 proliferation	 of	
fibroblasts	and	keratinocytes.	Most	importantly,	it	degrades	with	a	decline	in	its	




supporting	 the	 migration	 and	 proliferation	 of	 isolated	 human	 dermal	

















significant	 differences	 in	 cellular	 metabolic	 activity	 when	 isolated	 cells	 were	
seeded	on	monolayer	vs	trilayer	electrospun	scaffolds	apart	from	day	7	with	the	
monolayer	 constructs	 having	 significantly	 higher	 metabolic	 activity	 versus	
trilayer	 at	 this	 time	 checkpoint.	 Although	 in	 absolute	 terms,	 the	 trilayer	
constructs	had	lower	metabolic	activity	going	forward	to	21	days,	this	was	not	













































Monolayer PGLA 75:25 Scaffolds




Figure	 4.2.2	 Metabolic	 activity	 of	 skin	 explants	 on	 monolayer	 PGLA	 75:25	
electrospun	 scaffolds	 compared	 to	 	 non-templated	 PGLA	 75:25/PHBV		










The	 aim	 was	 to	 quantify	 the	 ability	 of	 the	 electrospun	 scaffolds	 to	 support	





























Skin Explants on Monolayer PGLA





























































































For	 these	 experiments,	 confluent	 dermal	 fibroblasts	 were	 seeded	 on	 both	
Monolayer	 75:25	 PGLA	 and	 non-	 templated	 trilayer	 PGLA	 75:25/PHBV	


























of	 cells	 versus	 skin	 explants	 on	 both	monolayer	 and	 trilayer	 scaffolds..	 	 The	
cellular	 nuclei	 appear	 as	 blue/black	 and	 the	 cytoplasm	 and	 surrounding	
connective	tissue	appears	pink.	H&E	stained	constructs	containing	cell	seeded	
monolayer	 and	 trilayer	 electrospun	 scaffolds	 demonstrated	 confluent	 cell	
populations	on	both	scaffolds(Figure	4.3.4).	A	distinct	difference	was	seen	in	the	
architectures	 whereby	 the	 trilayer	 scaffolds	 had	 a	 defined	 layer	 consisting	
predominantly	of	 keratinocytes.	 The	PHBV	basement	membrane	 layer	 is	 also	
visible	 in	 these	 constructs	 which	 is	 largely	 devoid	 of	 cellular	 material	 as	




sections	 of	 monolayer	 and	 trilayer	 electrospun	 scaffolds	 with	 explants	








of	 0.2	 mm	 (10X	 magnification).	
	
	






























Figure	4.3.5	Representative	 light	microscopy	H&E	stained	 sections	of	 isolated	
human	dermal	fibroblasts	and	keratinocytes	cultured	for	14	days	on	monolayer	
(x200)(A)	 and	 trilayer	 electrospun	 scaffolds	 (x40)(C)	 compared	 to	 human	









Figure	 4.3.6	 Representative	 light	 microscopy	 H&E	 stained	 sections	 of	 skin	



















of	 extracellular	 proteins	 and	 collagen	 fibrils	 that	 have	 been	 deposited	 by	 the	
proliferating	fibroblasts	are	visible	on	the	surface	of	the	scaffolds	(Figure	4.4.2).	
Imaging	 was	 also	 undertaken	 for	 the	 skin	 explant	 seeded	 constructs	 to	













































Figure	 4.5.1	 Immunohistochemistry	 staining	 of	 	 collagen	 IV	 (	 seen	 as	 green	 )	
produced	by		cultured	isolated	dermal	fibroblasts	and	keratinocytes	comparing	
the	collagen	organization	on	monolayer	PGLA	75:25	(	B	and	C)	and	trilayer	PGLA	


























microporous	 characteristics	 facilitate	 cellular	movement	 through	 the	 scaffold	
and	 its	microfibrous	 nature	 facilitates	 cellular	 proliferation,	 and	 ECM	protein	
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and	 collagen	 deposition	 due	 to	 its	 high	 surface	 area.	 Constructs	 containing	
monolayers	of	PGLA	75:25	only	therefore	exhibited	superior	ability	to	support	














seeded	 with	 skin	 explants.	 Furthermore,	 the	 DAPI	 images	 at	 21	 days	 of	
constructs	 containing	 skin	 explants	 seeded	 on	 monolayers,	 show	 significant	




















very	 thin	 and	 did	 not	 support	 the	 skin	 explants	 well.	 They	 were	 almost	
transparent	and	tore	very	easily	when	handled.		
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We	have	demonstrated	 that	 it	 is	possible	 to	spin	a	basement	membrane	 like	





skin.	 For	 example	 poly	 (caprolactone)	 (PCL)	 was	 blended	 with	 collagen	 to	
improve	 its	 mechanical	 properties	 for	 tissue	 engineered	 dermis(206).	
Additionally	 in	 vascular	 tissue	 engineering,	 synthetic	 polymers	 like	 PDS	 are	
blended	with	organic	proteins	like	gelatin	and	elastin	to	create	the	appropriate	
fibrous	 and	 porous	 network	 that	 will	 support	 endothelial	 cell	 development	
(207).		
In	 summary	 we	 have	 created	 a	 trilayer	 electrospun	 scaffold	 consisting	 of	 a	
basement	membrane	like	 layer	that	has	the	ability	to	support	organization	of	
cells	 and	 extracellular	 matrix	 which	 appear	 more	 like	 native	 human	 skin	

































both	 scaffold	 and	 cell	 source	need	 to	be	 synergistic	 in	order	 to	have	 an	end	
product	that	is	analogous	histologically	and	physiologically	to	human	skin.	Skin	
replacement	 can	 be	 thought	 of	 as	 epidermal,	 dermal	 and	 composite	 (both	
epidermis	and	dermis	present).	When	creating	a	dermal	equivalent	to	be	placed	
on	a	full	thickness	wound	bed,	a	clear	mechanism	of	epithelial	cell	source	and	




fact,	 all	 clinically	 available	dermal	 replacements	will	 require	 an	epithelial	 cell	
















process	 in	 itself	of	producing	CEA	 is	successful	 it	 is	a	 long	standing,	 tried	and	
tested	 technique	of	 cell	 culture.	 	However,	 there	are	 significant	barriers	 that	





but	 also	 having	 the	 appropriate	 HTA	 licensing	 which	 allows	 this	 work	 to	 be	
carried	out	in	the	facility.	Not	only	does	this	reflect	the	increased	cost	of	using	





attach	 to	 a	wound	 bed.	 As	 a	 result,	 the	 product	 in	 itself	 does	 not	meet	 the	










sites	 to	 safely	 resurface.	 For	 acute	 burns	 by	 and	 large	 these	 patients	 are	
physiologically	 unstable	 and	 their	 suitability	 for	 operative	 intervention	 are	
determined	 by	 daily	 clinical	 reviews.	 As	 a	 result,	 any	 change	 in	 the	 patient’s	
physiology	may	offset	surgical	intervention	which	may	result	in	wastage	of	the	





bed	 and	 a	 lack	 of	 infection.	 The	 take	 of	 CEA	 sheets	 is	 inconsistent	 and	 this	
actually	is	reflective	of	any	large	burn	as	several	factors	influence	take,	namely	
the	vascularity	of	the	wound	bed,	and	the	extent	of	the	immunological	hit	the	
patient	 has	 had.	 These	 factors	 are	 not	 easily	 influenced	 or	 predictable	 by	
objective	measures	(e.g.	a	blood	test)	therefore	using	CEA	sheets	may	well	have	
not	 have	 been	 inferior	 to	 split	 skin	 grafts	 however	 in	 order	 for	 a	 product	 to	




cases	 series	 and	 expert	 opinions	 which	 actually	 maybe	 the	 highest	 level	 of	
evidence	that	one	may	obtain	in	this	field	of	reconstructive	surgery.	Successful	
outcome	is	also	affected	by	the	experience	of	the	team	treating	the	patient	in	
firstly	making	 the	most	appropriate	 judgement	of	 the	material	 to	use,	 timing	
and	technique	application.	As	a	result,	it	is	not	surprising	that	some	groups	who	
may	have	more	clinical	experience	and	access	 to	close	 laboratory	 facilities	 to	





one	 can	 consider	 the	 need	 to	 steer	 away	 from	 laboratory	 expanded	 cells	 to	
populate	scaffolds	and	use	an	alternate	cell	source	with	respect	to	developing	a	
tissue	engineered	biodegradable	substitute.	Ideally	this	should	come	from	the	
patient	 themselves	 which	 reduces	 the	 immunogenicity	 associated	 with	 the	









day	3	and	 fibroblasts	at	day	7(31).	This	 is	advantageous	 in	 that	 in	cases	with	
small	 amount	 of	 tissue,	 it	 is	 a	more	 reproducible	 technique,	 it	 is	 technically	
simpler	 and	avoids	over	digestion,	 reduction	of	 cell	 viability,	 and	 subsequent	
attachment	of	cells	when	not	handled	properly.	Therefore,	the	principle	of	using	





laboratory	 and	 translated	 into	 clinical	 practice	 in	 the	 area	 of	 corneal	
regeneration.	In	brief,	damaged	corneas	are	regenerated	by	excising	the	non-






skin	 substitute.	 To	 do	 this,	 we	 needed	 to	 establish	 a	 control	 group	 with	 a	
standard	to	which	we	would	be	aiming	for	with	regards	to	cellular	proliferation	
and	migration.	The	first	set	of	experiments	establishes	the	ability	of	the	trilayer	
electrospun	 scaffolds	 to	 support	 isolated	 human	 dermal	 fibroblasts	 and	
keratinocytes.	To	do	this,	we	used	as	a	control,	the	original	tissue	engineered	
skin,	consisting	of	a	dermal	scaffold	of	DED,	to	which	we	populated	fluorescently	
labelled	 isolated	 human	 dermal	 fibroblasts	 and	 keratinocytes	 on	 either	 side.	
Additionally,	 we	 seeded	 the	 same	 cells	 on	 the	 trilayer	 electrospun	 scaffolds	
using	the	same	technique,	and	raised	all	constructs	to	an	air	liquid	interface	after	
3	days.	They	were	cultured	for	a	further	7,	14,	and	21	days	respectively.	Previous	
work	 conducted	 in	 the	 MacNeil	 lab	 has	 already	 established	 the	 ability	 of	
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This	 was	 undertaken	 at	 48	 hours	 following	 seeding	 of	 both	 isolated	 human	
dermal	 fibroblasts	 and	 keratinocytes	 on	 electrospun	 scaffolds	 and	 DED	 to	
confirm	 their	 presence.	 Fibroblasts	 were	 used	 between	 passage	 4-9	 and	
keratinocytes	between	1-3.	The	images	seen	demonstrate	green	fibroblasts	and	
red	keratinocytes	were	successfully	seeded	on	scaffolds	before	raising	it	an	air	
liquid	 interface	 and	 also	 the	 differing	 architectures	 of	 the	 scaffolds	 used	 in	
experiments	(Figure	5.1).			
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Figure	 5.1:	 	 Representative	 images	 of	 cell	 tracker	 fluorescence	 for	 isolated	





Absorbances	 for	 AlamarBlue	 treated	 cells	 seeded	 on	 templated	 and	 non-
templated	scaffolds	were	read	and	the	absorbance	 for	scaffolds	of	each	type	
seeded	 without	 cells	 were	 subtracted	 from	 these	 values	 for	 each	 time	
checkpoint	 of	 day	 0,	 7,	 14,	 and	 21	 (Figure	 5.2).	 Furthermore,	 the	 change	 in	

















metabolic	 activity	 of	 the	 cells	 seeded	 on	 the	 electrospun	 scaffolds	 to	 those	
seeded	on	tissue	engineered	skin	composites	using	DED	as	a	standard.	 It	was	
demonstrated	that	cellular	constructs	were	viable	throughout	the	21-day	testing	
period	 both	 on	 the	 scaffolds	 and	 the	 DED.	 	 Cellular	 metabolic	 activity	 in	
constructs	containing	electrospun	scaffolds	 initially	decreased	from	day	0	but	
then	steadily	increased	from	day	7	through	to	day	21.	There	were	no	significant	











Figure5.2	 Metabolic	 activity	 of	 isolated	 keratinocytes	 and	 fibroblasts	 on	
templated	 and	 non-templated	 electrospun	 scaffolds	 and	 DED	 over	 a	 21-day	




























































































constructs	 containing	 cell	 seeded	 templated	 and	 non-templated	 scaffolds	













Figure	 5.4	 Annotated	 light	 microscopy	 H&E	 stained	 sections	 of	 isolated	








Figure	 5.4.1	 Representative	 light	 microscopy	 H&E	 stained	 sections	 of	 cells	
seeded	on	non-templated,	templated	and	DED	scaffolds.	Scale	bars	of	0.2	mm	











At	day	7,	14,	and	21	Sirius	 red	assays	were	undertaken	 to	estimate	 the	 total	
collagen	produced	overtime	by	 the	 human	dermal	 fibroblasts	 seeded	on	 the	
templated	 and	 non-templated	 trilayer	 electrospun	 scaffolds	 (Figure	 5.5).	 The	
aim	was	to	quantify	the	ability	of	the	electrospun	scaffolds	to	support	cellular	
function	using	collagen	production	by	fibroblasts	as	a	marker	and	to	compare	
this	 to	 tissue	 engineered	 skin	 constructs	 containing	 DED	 as	 a	 standard.	 The	
absorbance	 of	 Sirus	 red	 is	 plotted	 in	 Figure	 5.5.1	 minus	 the	 absorbance	 of	
constructs	containing	scaffolds	without	cells.	There	was	no	significant	difference	
in	 total	collagen	produced	per	gram	of	scaffold	between	templated	and	non-
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5.3	 Culture	 of	 Skin	 Explants	 on	 Templated	 versus	 Non-templated	 Trilayer	
Electrospun	Scaffolds		
	
This	 experiment	 involved	 culturing	 skin	 explants	 onto	 templated	 and	 non-




giving	 the	 epithelial	 cells	more	 opportunity	 to	migrate	 from	 the	 skin	 pieces.	
Furthermore,	we	also	aimed	to	compare	if	there	was	any	difference	between	













was	 demonstrated	 that	 the	 skin	 explants	were	 viable	 throughout	 the	 21-day	
testing	period	both	templated	and	non-templated	scaffolds.			
Cellular	metabolic	 activity	 in	 constructs	 containing	 both	 templated	 and	 non-
templated	 electrospun	 scaffolds	 like	 those	 of	 the	 cell-seeded	 constructs	
decreased	from	day	0	to	day	7	but	then	steadily	 increased	through	to	day	21	
(Figure	5.6).	 There	was	no	 significant	difference	metabolic	 activity	when	 skin	
explants	 were	 seeded	 on	 templated	 versus	 non-templated	 electrospun	
scaffolds.	There	was	however	a	significant	difference	in	metabolic	activity	seen	
in	 cells	 seeded	 on	 DED	 compared	 to	 those	 seeded	 on	 templated	 and	 non-















































































































These	 were	 undertaken	 on	 fixed	 constructs	 at	 day	 7,	 14,	 and	 day	 21	 to	
demonstrate	 consecutive	 cellular/scaffold	 architectures.	 The	 cellular	 nuclei	
appear	 as	 blue	 black	 and	 the	 cytoplasm	 and	 surrounding	 connective	 tissue	
appear	pink.	Frozen	sections	of	constructs	containing	skin	explant	cultured	on	
non-templated	(Figure	5.8.)	and	templated	(5.8.1)	scaffolds	demonstrated	with	






ECM	 production	 between	 constructs	 seeded	 with	 isolated	 cells	 (both	
electrospun	scaffolds	and	DED)	and	those	cultured	with	skin	explants	with	the	














At	day	7,	14,	and	21	Sirius	 red	assays	were	undertaken	 to	estimate	 the	 total	
collagen	produced	overtime	by	the	skin	explants	seeded	on	trilayer	electrospun	
scaffolds	(Figure	5.9).	The	aim	was	to	quantify	the	amount	of	collagen	deposited	
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The	 aims	 of	 the	 first	 set	 of	 the	 experiments	 in	 this	 chapter	 were	 to	 firstly	
determine	if	cells	would	be	able	to	proliferate	along	the	fibres	of	the	templated	
scaffolds	and	function	so	as	to	start	 formation	of	an	extracellular	matrix.	 It	 is	
known	 that	 electrospun	 scaffolds	 are	 cell	 conductive,	 however	 the	 idea	 of	
investigating	the	effect	of	templating	scaffolds	so	as	to	provide	a	stem	cell	niche	





significant	 differences	 were	 noted	 in	 the	 ability	 for	 templated	 electrospun	
scaffolds	 to	support	cellular	migration	and	proliferation	as	compared	 to	non-








cells	would	have	 fallen	between	 the	micropores	 of	 the	PGLA	 fibres	 onto	 the	








be	 a	 significant	 difference	 in	 templated	 versus	 non-templated	 scaffolds	
suggesting	that	over	time	and	longer	culture	periods,	this	scaffold	architecture	
was	more	conductive	to	cellular	migration	and	proliferation.		
Furthermore,	 it	 was	 demonstrated	 that	 cells	 were	 confluent	 over	 -and	













produce	 collagen	 in	 constructs	 containing	 electrospun	 scaffolds.	 The	 data	
presented	thus	far	highlights	the	fact	that	the	templated	scaffolds	supports	the	









the	metabolic	activity	of	 constructs	 containing	 templated	and	non-templated	





finding	 was	 supported	 by	 the	 fluorescent	 images	 using	 DAPI	 staining	 that	
illustrated	 very	 little	 outward	 migration	 of	 cells	 from	 the	 cut	 edges	 of	 the	





constructs,	 as	 expected	 the	 histology	 process	 resulted	 in	 destruction	 of	
electrospun	 scaffold	 architecture	 and	 topography.	 	 This	 finding	 was	 also	
reflected	 in	 the	 assessment	 of	 collagen	 deposition	 quantified	 by	 Sirius	 Red	
Assays.	Although	there	was	some	collagen	production,	we	postulate	that	 this	
was	 mainly	 due	 to	 the	 natural	 collagen	 contained	 in	 the	 skin	 explants	
themselves	 as	 opposed	 to	 fibroblast	 integration	 and	 function	 on	 the	 trilayer	
scaffolds,	one	limitation	of	our	study	was	that	it	was	very	difficult	to	determine	
the	amount	of	collagen	that	were	present	in	the	skin	explants	as	a	control.	This	
would	 involve	 undertaking	 Sirus	 red	 on	 a	 fixed	 sample	 and	 assume	 that	 this	
sample	was	 representative	 of	 all	 the	 repeats	 used,	 however	 there	would	 be	
significant	variation	in	the	various	batches	of	skin	with	regards	to	the	amount	of	





and	 tissue	 engineered	 skin	 models	 containing	 DED	 (Figure	 5.5).	 The	 data	
presented	here	also	suggests	that	the	use	of	isolated	cells	on	trilayer	electrospun	
scaffolds	 resulted	 in	 constructs	 with	 significantly	 better	 overall	 cellular	
proliferation,	integration	and	function	as	opposed	to	using	skin	explants	as	a	cell	
source.	 	 The	 cells	 contained	 in	 the	 skin	 explants	 are	 viable	 throughout	 the	
experimental	time	period	and	in	theory	have	the	ability	to	migrate	from	the	cut	
edge	 of	 the	 skin	 explants	 onto	 the	 fires	 of	 the	 electrospun	 scaffold.	 This	
technique	as	mentioned	in	the	introduction	is	taken	from	the	principles	of	Meek	
Grafting,	where	small	squares	are	cut	from	split	thickness	skin	and	placed	onto	
a	wound	bed.	 This	 results	 in	 cellular	migration	 from	 the	 edge	of	 the	 grafted	
squares	of	split	thickness	skin	and	re-epithelisation	of	the	wound	bed.	However,	













this	 technique	 is	modelled	on	 the	 successful	 clinical	 application	of	meek	 skin	
grafting,	this	led	us	to	believe	that	our	skin	explant	model	needed	to	be	refined.	
There	 should	 be	 a	 reasonable	 explanation	 for	 this	 lack	 out	 outward	 cellular	
growth.	Therefore,	we	postulated	that	there	were	two	main	factors	that	could	
contribute	to	this	lack	of	outward	cellular	migration,	firstly	the	properties	of	the	
skin	 explant	 themselves	 and	 the	 interaction	 between	 the	 skin	 explants	 and	
scaffolds.		
With	regards	to	the	skin	explants	themselves,	it	is	known	that	the	keratinocytes	
and	 fibroblasts	 without	 the	 appropriate	 chemical	 signalling	 will	 not	 be	
stimulated	 to	 leave	 the	 skin	 explant	 and	 migrate	 onto	 the	 fibres	 of	 the	
electrospun	 scaffold.	 To	 migrate	 over	 a	 wound	 site,	 the	 keratinocytes	 must	
disengage	their	desmosome/hemidesmosomes	junctions	and	re-organize	their	
cytoskeleton.	 As	 re-epithelization	 continues	 keratinocytes	 once	 again	 by	





with	 keratinocytes	 in	 order	 to	 stimulate	 growth	 and	 proliferation(211).	
Keratinocytes	 whilst	 in	 culture	 instruct	 fibroblasts	 to	 synthesize	 and	 secrete	
growth	 factors	 and	 cytokines	 like	 keratinocyte	 growth	 factor	 (KGF)/fibroblast	
growth	 factor-7	 (FGF7),	 IL-6,	 and	 GM-CSF(212).	 	 This	 in	 turn	 stimulates	 the	
migration	 and	 proliferation	 of	 keratinocytes	 and	 ultimately	 wound	
epithelization	resulting	 in	 this	double	paracrine	 loop.	 In	 the	absence	of	 these	
signalling	 proteins	 migration	 of	 these	 cells	 does	 not	 occur.	 This	 could	 be	 a	
possible	explanation	of	the	lack	of	migration	of	keratinocytes	and	fibroblasts	in	
our	 novel	 tissue	 engineered	 skin	model	 containing	 electrospun	 scaffolds	 and	
skin	explants.	Additionally,	cells	will	only	migrate	out	of	the	explants	where	it	is	
in	 direct	 contact	 with	 the	 fibres	 of	 the	 electrospun	 scaffolds.	 This	 will	 be	
increased	 in	 constructs	 in	which	 isolated	 cells	 are	 used	 as	 compared	 to	 skin	
explants	as	there	will	be	greater	number	of	contact	points	between	the	scaffold	
fibres	 and	 isolated	 cells	 versus	 skin	 explant	 and	 fibres	 as	 the	 cells	 are	 still	









migration	 and	 proliferation.	 In	 our	 in	 vitro	 constructs	 the	 skin	 explants	 are	
simply	placed	on	top	of	the	electrospun	scaffolds	without	any	method	to	secure	
their	contact.	Furthermore,	media	changes	which	are	required	result	in	physical	
disturbances	 to	 this	 contact.	 Therefore,	 we	 need	 to	 refine	 this	 in	 vitro	 skin	
explant	model	to	allow	for	a	more	secure	contact	between	the	skin	explants	and	











































to	 assess	 potential	 strategies	 to	 aid	 retention	 of	 the	 skin	 explants	 onto	 the	












The	aim	 is	 to	 achieve	 a	 level	 of	 cellular	migration	 similar,	 or	 close	 to	 that	of	
seeding	 isolated	 cells	 on	 electrospun	 scaffolds.	 In	 terms	 of	 wound	 healing,	
fibroblasts	 begin	 proliferating	 to	 form	 type	 III	 collagen	 from	 the	 fourth	 day	
following	injury	for	up	to	2-4	weeks	thereafter	to	replace		dermal	breaches(213).	





is	 due	 to	 the	 technique	 itself	 and	 the	 presence	 of	 a	 suitable	 wound	 bed	
containing	 the	 appropriate	 architecture	 and	 signalling	 molecules	 that	 are	
essential	 for	 fibroblast	 and	 keratinocyte	 migration	 and	 proliferation.	 The	
surgical	technique	of	Meek	grafting	has	been	refined	over	time,	but	its	principle	

















electrospun	 scaffold,	which	 is	what	would	normally	 occur	when	explants	 are	
placed	onto	a	wound	bed.	In	order	to	address	these,	this	chapter	aims	to	assess	
various	 strategies	 to	 aid	 retention	 of	 the	 skin	 explants	 onto	 the	 electrospun	
scaffolds	thereby	optimizing	the	migration	of	skin	cells	along	the	scaffold	fibres.		
The	 first	 strategy	 assessed	 the	 use	 of	 fibrin	 to	 fix	 the	 skin	 explants	 onto	 the	
electrospun	scaffold.	We	investigated	this	using	both	laboratory	made	fibrin	gels	
of	 varying	 fibrin	 concentrations,	 and	 a	 clinically	 available	 product	 TISSEEL™:	
(Baxter	 Healthcare	 Corp,	 Deerfield,	 IL,	 USA).	 Furthermore,	 we	 aimed	 to	
determine	whether	or	not	 the	dermal	 thickness	of	 the	 skin	explants	had	any	













prothrombin.	 Thrombin	 converts	 fibrinogen	 to	 fibrin.	 Fibrinogen	 is	 a	 soluble	
glycoprotein,	which	when	exposed	to	thrombin	results	in	cleavage	of	two	small	
peptides	(fibrinopeptides	A	and	B).	This	results	in	the	formation	of	protofibrils	
that	 aggregate	 to	 form	 insoluble	 fibrin	 fibres.	 	 The	 fibrin	 network	 is	 further	
stabilized	by	activated	factor	XIII,	as	the	network	can	undergo	early	degradation	
by	a	serine	protease	called	plasmin(214)(148).	This	fibrin	network	has	multiple	
functions.	 Firstly,	 it	 reinforces	 the	 initial	 platelet	 plug	 by	 trapping	 platelets,	
erythrocytes,	 and	 other	 proteins	 to	 stop	 bleeding.	 It	 also	 serves	 as	 an	 initial	
template	 for	promoting	cellular	migration	and	proliferation	as	 it	 is	 filled	with	
cytokines	 and	 growth	 factors	 which	 promote	 re-epithelization,	 angiogenesis,	
and	 collagen	 deposition(215).	 Furthermore,	 fibroblasts	 from	 surrounding	
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uninjured	tissue	are	stimulated	both	by	growth	factors	 from	within	the	 fibrin	
network	 and	 the	 network	 itself	 to	 migrate	 towards	 the	 matrix.	 Fibroblasts	
express	 integrin	 receptors,	 proliferate,	 and	 produce	 extracellular	 matrix	
components	 to	 replace	 the	 temporary	 fibrin	 network.	 Keratinocytes	 are	 also	
stimulated	by	 the	 fibrin	network	 to	detach	 themselves	 from	 the	 surrounding	
healthy	 wound	 edges	 and	 migrate	 towards	 it-	 instituting	 the	 process	 of	 re-
epithelization(216)(16).		
	
The	 concentration	 of	 thrombin	 at	 the	 time	 of	 fibrin	 clot	 formation	 has	 a	
significant	influence	on	fibrin	clot	structure(217).	Extremely	low	concentrations	
of	thrombin	(<1nM,	<	0.1	U/mL)	produce	turbid	clots	composed	of	thick,	loosely	
woven	 fibrin	 strands.	 Higher	 concentrations	 of	 thrombin	 produce	 relatively	
thinner	 fibrin	 clots	 composed	of	 tightly	packed	 fibrin	 strands(218).	 Thrombin	
becomes	inactivated	once	the	fibrin	clot	has	formed.	Fibrin	is	attractive	for	use	
in	 tissue-engineered	 skin.	 Firstly,	 it	 serves	 as	 a	 stimulus	 to	 promote	 cell	
adhesion,	migration	and	proliferation.	Additionally,	fibrin	precursors	thrombin	
and	 fibrinogen	can	be	easily	 isolated	 from	patient’s	blood	 thereby	creating	a	
custom	autologous	treatment.	In	this	regard,	the	fibrin	clot	should	have	a	porous	
structure	to	facilitate	cellular	movement	and	function	but	at	the	same	time	be	
mechanically	 strong	 to	 combat	 shear	 forces	 that	 can	occur	between	 the	 skin	
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explants	and	the	electrospun	scaffolds.	Furthermore	increasing	the	fibrinogen	
concentration	 results	 in	 a	 clot	 with	 an	 increased	 tensile	 and	 adhesion	
strength(219).	
	
We	 tested	 three	 concentrations	 of	 thrombin	 and	 three	 concentrations	 of	
fibrinogen.	The	first	concentrations	tested	were	based	on	that	used	in	previous	
studies	performed	in	the	MacNeil	laboratory	on	corneal	explants.	Ortega	et	al	





adhesives	were	 chosen	 as	models	 for	 our	 concentrations.	 Fibrin	 is	 used	 as	 a	
haemostat	 in	 cases	 of	 bleeding	 which	 is	 not	 controllable	 by	 suturing	 or	
cauterization	of	vessels	e.g.	solid	organ	 lacerations.	 In	 this	case	the	thrombin	
concentration	used	is	often	greater	than	500	I.U/ml,	this	high	concentration	of	
thrombin	would	result	in	a	tightly	compact	fibrin	clot	that	sets	instantly,	which	
is	a	requirement	of	 its	 function	as	a	haemostat.	 	However,	 this	would	not	be	
suitable	for	our	in	vitro	studies.	Other	thrombin/fibrinogen	concentrations	used	
are	 based	 on	 the	 approximate	 concentrations	 from	 these	 clinical	 products.	
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Thrombin/fibrinogen	concentration	of	2.5-6.5	 I.U	/	67-86.5mg/ml	 is	based	on	




to	 position	 the	 grafts	 or	 flaps	 before	 the	 fibrin	 starts	 to	 set.	 The	 fibrinogen	
concentration	in	this	product	ranged	from	67	to	106	mg/ml	with	an	average	of	










–	 625	 units/mL	 and	 a	 fibrinogen	 concentration	 ranging	 from	 67	 –	 106	
mg/mL(221).	As	 this	preparation	 is	FDA	approved,	widely	available,	and	used	








standardized	 thicknesses:	 Thiersch	 grafts	 (0.008–0.010	 inches;	 0.2–0.25mm),	
STSGs	 (0.012–0.016inches;	 0.3–0.4mm),	 three-quarter	 skin	 grafts	 (0.018–
0.022inches;	0.45–0.55mm),	and	full	thickness	skin	grafts	(0.030	–0.038	inches;	
0.75–0.95mm)(50).		
He	 concluded	 that	 using	 grafts	with	 less	 dermis	was	 suitable	 for	 granulating	
wound	bases	and	grafts	with	more	dermis	for	wounds	that	would	require	more	
substantial	coverage	to	avoid	contractures	e.g.	over	joint	surfaces.	The	dermal	
thickness	 of	 a	 graft	 is	 dependent	 on	 the	 technique	 used,	 the	 quality	 of	 the	
patient’s	skin	(age,	drugs	and	other	co-morbidities),	and	the	chosen	donor	site.	
Areas	like	the	inner	arm	and	thigh	have	thinner	dermis	and	result	in	such	grafts	
being	 thinner	 than	grafts	 from	donor	sites	 like	 the	abdomen,	back	and	outer	
thigh.		










	In	 our	 experiment	 we	 divided	 the	 skin	 explants	 into	 two	 groups	 based	 on	
varying	dermal	thickness	measured	with	a	digital	micrometer,	as	the	epidermal	


























































A	 2.5		 18.75	 67	 86.5		
B	 4.5	 18.75	 67	 86.5		
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T 6.5 I.U F 67mg 
T 6.5 I.U F 86.5mg 
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Skin explants cultured on 
fibroblast impregnated 
scaffolds without fibrin 
Skin explants cultured on 
fibroblast impregnated 
scaffolds with fibrin 
Skin explants cultured on 
plain scaffolds with no 
fibrin 
Co culture with fibrin
Skin Explants and Scaffold























































B= Skin explants 



























































































































































































































































































































































































































































































































4. Evaluation	of	whether	 inclusion	of	 fibroblasts	 in	 the	 templated	 trilayer	

























































































































































































































































































































































































































































































































































































































































































































































































































































































































Consent form for using samples of human skin for research 
• Thank you for reading the information about our research.
• If you would like to take part, please read and sign this form,
     a copy of which will be retained in your medical records. 
Centre: 
Department of Plastic Surgery, Sheffield Teaching Hospitals Trust
Title of project: Development of tissue engineered wound models for wound healing research for 
patients with burns and chronic wounds. 
Name of Researcher:  Professor Sheila MacNeil 
Contact details for research team:  Professor Sheila MacNeil, Biomaterials &Tissue Engineering 
Group, University of Sheffield, Kroto Research Institute, North Campus, Broad Lane,  
Sheffield, S3 7HQ. 
Tel: +00 44 (114) 222 5995 
Please Initial in the box 
1. I have read the attached information sheet for this project, (version 3 dated 13/04/2016) and 
have been given a copy to keep. I have been able to ask questions about the project and I 
understand why the research is being done and any risks involved.
2. I do understand that some cells from the samples may be used in animal work.
3. I agree to give a sample of skin for research in this project. I understand how the sample will be
collected, and that giving a sample for this research is voluntary.
4. I understand that I will not benefit financially, or otherwise, if this research leads to the
development of a new treatment or medical test.













































A Research Ethics Committee established by the Health Research Authority  
 
 
NRES Committee Yorkshire & The Humber - Sheffield 
Jarrow Business Centre 
Viking Business Park 
Rolling Mill Road 
Jarrow 
Tyne and Wear 
NE32 3DT 
 
Telephone: 0191 4283564 
03 June 2015 
 
Prof Sheila MacNeil 
Kroto Research Institute 
University of Sheffield 




Dear Prof MacNeil 
 
Title of the Research Tissue Bank: Research Tissue Bank 
REC reference: 15/YH/0177 
Designated Individual: Prof Sheila MacNeil 
IRAS project ID: 128409 
 
Thank you for your letter of 21 May 2015, responding to the Committee’s request for further 
information on the above research tissue bank and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair. 
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the date 
of this favourable opinion letter.  The expectation is that this information will be published for all 
studies that receive an ethical opinion but should you wish to provide a substitute contact point, 
wish to make a request to defer, or require further information,, please contact the REC 
Manager Miss Kathryn Murray, nrescommittee.yorkandhumber-sheffield@nhs.net. Under very 
limited circumstances (e.g. for student research which has received an unfavourable opinion), it 
may be possible to grant an exemption to the publication of the study. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion of the above 
research tissue bank on the basis described in the application form and supporting 
documentation as revised. 
 
Duration of ethical opinion 
 
The favourable opinion is given for a period of five years from the date of this letter and provided 
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